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 Overview  
 
The following thesis contains three sections.  
Section one:  Review of the literature, with an emphasis on TMD presentation and 
prevalence, diagnosis, associated conditions and contributing factors in TMD aetiology, and 
a critical review of the current literature surrounding TMD interventions including 
pharmacological, dental, surgical and manual therapy interventions. 
Section two:  Reports a single system design investigating the effectiveness of intra-oral 
osteopathic techniques for chronic temporomandibular disorders presented in a manuscript 
format designed for submission to the International Journal of Osteopathic Medicine. 
Section three:  Appendices including participant information sheet, consent form, McGill pain 
questionnaire short form, visual analogue scale, temporomandibular disability, newspaper 
articles, recruitment flyers, ethics approval letters and the guidelines for authors to the 
International Journal of Osteopathic Medicine. 
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1. Temporomandibular Disorder - Introduction 
 
Temporomandibular disorder (TMD) is a term encompassing disorders of the 
temporomandibular joint (TMJ) muscles of mastication and associated neck and craniofacial 
structures resulting in ongoing pain and dysfunction of the TMJ (LeResche, 1997).  TMD 
implies a variety of joint and muscle afflictions with a variety of pathological characteristics 
(deBont et al, 1997)   Conditions affecting the TMJ are multifactorial and while TMD is a 
widely used term to describe the condition, it is without standardization.  Craniomandibular 
syndrome or disorder (McNeill Et al, 1980), temporomandibular pain and dysfunction 
syndrome (Merksey, 1986) and orofacial pain and dysfunction (Okeson and de leeuw, 2011) 
are amongst a plethora of terms used to describe conditions relating to disorders of the TMJ.  
The TMJ is one of the most complex and frequently used joints in the body through speech, 
mastication, breathing and other facial expressions (Alomar et al. 2007). 
 
TMD can be sub-categorized into myogenous, arthritic, or discal presentations, myogenous 
and discal being the most common, however prevalence across subtypes is variable with 
many overlapping symptoms (Manfredini et al., 2011).   TMD predominantly affects young to 
middle aged adults with the onset of symptoms commonly reported in adolescence and 
diminishing after the age of 65 years (Dworkin, LeResche, & Von Korff, 1990; LeResche, 
1997).  Signs and symptoms can range from mild to severe with 30% of people having a 
perceived experience of TMD and 44% having a clinically assessed dysfunction in a Dutch 
epidemiological study  (Conti, Ferreira, Pegoraro, Conti, & Salvador, 1996; De Kanter et al., 
1993), Furthermore, up to 6% of people will experience persistent pain requiring them to 
seek treatment (Svensson & Graven-Nielsen, 2001).  Pain is generally intermittent, but may 
be constant, with a dull, aching quality often exacerbated by mandibular movements such as 
mastication and yawning (Merskey, 1986). 
 
The pain and discomfort caused by chronic temporomandibular joint disorders affects 
everyday living and quality of life (Scrivani, Keith, & Kaban, 2008).  Persistent muscular pain 
significantly effects and alters craniofacial motor function and somatosensory function 
causing pain referral to other areas (Scrivani et al., 2008).  This literature review comprises a 
description of the nature of TMD, the presentation, diagnosis, contributing factors in TMD 
aetiology, and a critical review of the current literature surrounding TMD interventions such 
as invasive and non-invasive treatments including pharmaceutical therapy, occlusal splints, 
education, self care and manual therapy techniques. 
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2. Overview of Temporomandibular Joint Anatomy 
 
The masticatory system is a complex functional unit controlled and regulated by neurological 
coordination of bones, muscles, ligaments, teeth, joints and articular cartilage (Okeson, 
2007).  The ellipsoid joints allow for movement of the mandible against the concave 
mandibular fossa of the cranium and articulate with a mobile and pliable biconcave 
fibrocartilage disc located between the articular surfaces of each bone (Kapandji, 
2008).  The intra-articular disc glides inside the concavity of the joint and follows the 
movements of the mandible (Kapandji, 2008); it is flexible during movement, highly 
adaptable and essential for the continuation of temporomandibular joint stability (Deodato, 
Cristiano, Trusendi, & Giorgetti, 2003; Okeson, 2007).  Functional movement of the joint 
creates a pumping action of synovial fluid for joint nourishment, providing metabolic 
requirements and lubricating the avascular articular surfaces, thereby maintaining healthy 
cartilage (Tanaka et al, 2008).  The intra-articular disc is attached posteriorly via highly 
vascularized and innervated retro-discal connective fibres.  Elastic fibres form a superior 
attachment to the tympanic plate, while collagenous fibres connect inferiorly to the condylar 
articular surface, and the remaining body of tissue connects to a large venous plexus which 
fills with blood as the condyle glides anteriorly (Alomar et al, 2007; Okeson, 2007).  
Anteriorly the fibrous capsular ligament attaches to the disc connecting to the temporal bone 
superiorly, condylar articular surface inferiorly and centrally gives insertion to the lateral 
pterygoid tendon (Alomar et al, 2007).  
 
The two TMJ’s are mechanically linked and one cannot function without the other.  Closure 
of the jaw is facilitated by bilateral contraction of the primary muscles of mastication; 
temporalis, masseters and medial pterygoids.  The lateral pterygoid muscle is a small yet 
vital muscle in the function of mouth opening.  The muscle pulls the articular disc forward 
and contributes to protrusion of the chin and tilting of the mandible around its centre of 
rotation during opening.  This movement is enabled via the muscle’s attachments from the 
pterygoid process to the anterior aspect of the neck of the mandibular condylar process; the 
condylar process would remain wedged in the mandibular process without the action of this 
muscle (Kapandji, 2008). Since both joints are linked by a single mandible, movement is 
guided not only by the muscles, ligaments and the shape of the bones but also by the 
occlusion of teeth (Alomar et al. 2007).  Malalignment of teeth and occlusional instability may 
result in dysfunction of the muscles leading to damage of the joint itself (Alomar et al, 2007) 
Variation exists in the morphology of the lateral pterygoid muscle.  Two functional heads 
were found to be present in a large majority (65%) of subjects, with a further 20% having 
three functional heads and 15% having only a single head (Naohara, 1989). In those with 
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two functional heads the function of the inferior head is for opening, protrusion and 
contralateral jaw movements while the superior head is active upon clenching, retrusion and 
ipsilateral jaw movements therefore the lateral pterygoid muscle has a significant influence 
on the position and function of the TMJ (Murray, Phanachet, Uchida, & Whittle, 2004).  
Hiraba, Hibino, Hiranuma, and Negoro (2000) found that the superior head regulates the 
relationship of the angle of articular disk upon the condyle.  However the disk position in 
relation to the maxilla is controlled by the inferior head due to the ligamentous attachment.  
Innervations from the mandibular branch of the trigeminal nerve have been found to pass 
through the fibres of the lateral pterygoid muscle.  Nerves may then become compressed or 
entrapped in a spastic lateral ptergoid muscle leading to numbness or pain in areas of the 
nerve distribution (Loughner, Larkin, & Mahan, 1990). The TMJ is a complex joint; evaluating 
the biomechanics enables greater understanding of the structure and function of the joint to 
implement more efficient treatment protocols (Ingawalé, & Goswami, 2009). 
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3. Presentation of Temporomandibular Disorder 
  
Most people will experience symptoms of TMD at some point in their life and many people 
experience mild symptoms without ever having to seek treatment (Svensson & Graven-
Nielsen, 2001).  Reported signs and symptoms include jaw clicking or crepitus, resting, 
opening and clenching pain, chronic headaches, decreased inter-incisal range of motion, 
tinnitus and other ear problems, dizziness, vertigo, deviation of the mandible upon opening 
and hypertonicity and tenderness in the muscles of mastication (Bagis, Ayaz, Turgut, 
Durkan, & Özcan, 2012; Chole & Parker, 1992).  Movements such as yawning, maximal 
mouth opening for prolonged periods of time, and chewing gum or hard foods can place 
increased strain on the joint and associated structures resulting in further pain and irritation 
of the joint (Pierson, 2011).  
 
Aetiology and pathophysiology is multifactorial and remains largely unknown (Mohl, 1993), 
however prevalence of TMD is higher in the company of conditions such as bruxism 
(Ciancaglini, Gherlone, & Radaelli, 2001), fibromyalgia (Plesh, Wolfe, & Lane, 1996), 
breathing pattern disorders (Bartley, 2011), ligament laxity (Deodato, Trusendi, Giorgetti, & 
Scalese, 2006), microtrauma (Kim, Yun, Ahn,& Kim,2009), malocclusion (Tanne, Tanaka, & 
Sakuda, 1992), vitamin inadequacy Levy & Gorlin, 1953, whiplash widespread pain, pain 
catastrophizing (Buenaver et al., 2012) and psychosocial issues (Fillingim et al., 2011).  
Recent studies have also linked several genes predisposing people to the disorder (Smith et 
al., 2011; Smith et al., 2013).  A high number of individuals with chronic TMD also have neck 
pain and in turn those with chronic neck disorders have a higher rate of TMD symptoms 
(Nicolakis et al., 2002).  Symptoms are also associated with postural abnormalities and 
shoulder pain.  A higher number of body sites with pain are described by chronic TMD 
patients than those with remittent TMD (John, Miglioretti, LeResche, Von Korff, & Critchlow, 
2003).  Chen, Slade, Lim, Miller, Maixner and Diatchenko (2012) reported that TMD 
sufferers can further experience widespread body palpation tenderness due to an 
association between the pathophysiological pathways and alteration of pain processing 
leading to poorer treatment outcomes and persistence of TMD symptoms.  TMD is five times 
more common in females which research suggests may be related to fluctuations in 
hormones (estradiol and estrogen) during the menstrual cycle (Turner et al., 2011).  Oral 
contraceptive use may also have an effect on the activity of masseter and anterior temporal 
muscles (Song et al., 2014), however, Turner et al. (2011) suggest that continuous oral 
contraceptive use may stabilize hormones that influence TMD. 
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4. Diagnosis of Temporomandibular Disorder 
  
Diagnosis of TMD is made through clinical history, examination findings and clinical tests 
and can be confirmed through diagnostic imaging.  The Research Diagnostic Criteria for 
Temporomandibular Disorders (RDC/TMD) is a widely used protocol for TMD diagnosis 
(Schiffman et al., 2014).  Since its first publication in 1992 (Dworkin, 1992) the validity and 
reliability of the RDC/TMD has been tested and republished to be a standardized diagnostic 
scheme (Schiffman et al., 2014).  The RDC/TMD is based on the biopsychosocial pain 
model and consists of two axes.  The first axis investigates the physical signs and symptoms 
and the second axis assesses psychological status and pain oriented disability in order to 
identify any underlying relevant patient characteristics (Schiffman et al., 2014).  The latest 
version (DC/TMD) identifies the most common TMD diagnoses in axis one (Schiffman et al., 
2014).  Firstly myalgia or myogenic pain, local myalgia, myofascial pain and myofascial pain 
with referral, arthralgia and headache attributed to TMD.  Secondly, disc displacement with 
reduction, disc displacement with reduction and intermittent locking, disc displacement 
without reduction with limited opening, disc displacement without reduction without limited 
opening, degenerative joint disease and subluxation (Schiffman et al., 2014).  Among TMD 
patient populations, myofascial pain with or without opening limitation is the most common 
diagnosis (Manfredini et al., 2011).  The second axis contains scales to evaluate pain 
behaviour, psychological status and psychosocial functioning.   Other early diagnostic tools 
include the Helkimo Index and the Craniomandibular Index.  The Helkimo index has been 
found to be less accurate than the craniomandibular index and evidence to support the 
general applicability of the Helkimo index is insufficient (Cunha et al., 2007; Weele & 
Dibbets,1987).  The Craniomandibular Index has been found to be reliable for use in 
epidemiological and clinical studies, however, numerous items within the tool are subjective 
and therefore strict methodological guidelines are required for accuracy (Fricton & 
Schiffman, 1986; Fricton & Schiffman, 1987). 
 
Provocation tests for diagnosis of TMJ disorders include range of motion of the mandibular, 
temporalis muscle palpation, bite tests and clench tests, compression, traction and 
translation as well as static and dynamic orthopaedic jaw tests.  Presence of familiar pain 
indicates a positive test. (Schiffman Et al, 2012).  Saito, Akashi, and de Camargo Neves 
Sacco (2009) found that among patients with TMJ disc displacement, there was a higher 
incidence of pain in the TMJ area in those with concurrent postural deviations ranging from 
posterior rotation of the pelvis, lumbar spine hyperlordosis, head deviation to the right and 
mandible deviation to the left with open mouth.  Additionally, in a text outlining the principles 
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of cranialsacral therapy, Upledger (1987) suggested that TMD may originate from sacral 
dysfunction.  There are thus, possible links between whole body posture and TMD, 
suggesting that examination beyond the TMJ may be warranted. 
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5. Chronic pain and Psychosocial Relationship with Temporomandibular Disorder 
 
Pain is a personal, subjective experience with many influences and is defined as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue 
damage, or described in terms of such damage.” (Merskey & Bogduk, 1994).  Pain can be 
classified as acute or chronic, and management is determined by classification.  Acute pain 
has a duration of under three months and generally occurs as a result of injury or tissue 
damage (Conn, 2005).  Even brief occurrences of acute pain can result in chronic pain, 
along with psychological distress and long term neuronal remodeling and sensitization (Carr 
& Goudas, 1999).  Chronic pain is described as pain persisting for at least twelve weeks 
duration following onset (Merskey & Bogduk, 1994).  Chronic pain occurs in 19% of people 
and seriously affects quality of social and working lives (Breivik, Collett, Ventafridda, Cohen, 
& Gallacher, 2006).  Furthermore, nearly half of those with chronic pain have inadequate 
management of their pain suggesting a need for greater chronic pain management (Breivik, 
Collett, Ventafridda, Cohen, & Gallacher, 2006).  Vlaeyen and Linton (2012) describe the 
varying threats a pain stimulus can have from person to person and across context and that 
the protective response and fear avoidance behaviours brought on initially may worsen the 
problem long term.  Chronic TMD shares many psychosocial features of other chronic pain 
conditions (Dworkin & Massoth, 1994). 
 
Previous studies in aetiology, diagnosis and management of TMD address the important role 
of psychosocial factors such as increased stress, anxiety, depression, somatization, chronic 
pain syndrome and pain perception/response (Pankhurst, 1997; Suvinen, Reade, 
Kemppainen, Könönen, & Dworkin, 2005).  Psychosocial distress may occur as a result of 
chronic TMD or, it may provoke the development of symptoms (Fillingim et al., 2011; Huang, 
LeResche, Critchlow, Martin, & Drangsholt, 2002).  Those who suffer from TMD report 
reduced general health state and higher rates of depression and anxiety (Shedden Mora, 
Weber, Borkowski, & Rief, 2012).  Pain severity is found to be greater in myogenic 
presentations, increasing the likelihood of enhanced psychological distress and overlap with 
chronic pain syndromes in patients (Pankhurst, 1997).  Furthermore, stress related 
syndromes such as irritable bowel syndrome, premenstrual syndrome and chronic fatigue 
are often reported by TMD sufferers (Shedden Mora et al., 2012). 
 
Masseter muscle tension is known to increase with mental stress (Flor, Birbaumer, Schulte, 
& Roos, 1991) and has an acute haemodynamic effect on jaw muscles (Tanosoto, Arima, 
Tomonaga, Ohata, & Svensson, 2012).  Recently, Song et al. (2014) found that masseter 
muscle tone was increased by raised levels of glutamate in the trigeminal motor nucleus 
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when stressed.  Stress and anxiety initiate a sympathetic response resulting in poor posture 
and increased clenching and grinding which creates tension throughout the muscles of 
mastication, face and neck as well as damaging the teeth, resulting in misalignment of the 
jaw (Dworkin & Massoth, 1994).  Further to this, dysfunctional breathing patterns are thought 
to initiate increased sympathetic drive leading to feelings of stress and anxiety, resulting in 
chronic jaw clenching and TMD (CliftonSmith & Rowley, 2011).  Management of 
biopsychosocial factors in TMD should be multifactorial. The structural and the emotional 
presentations differ from one another, and as such, having a greater understanding of the 
psychosocial factors determines a more favourable outcome (Hampf, 1990). 
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6. Bruxism and Temporomandibular Joint Disorder 
  
The phenomenon of bruxism is multifaceted and an acceptable standardization of diagnosis 
has only been achieved in recent years (Manfredini & Lobbezoo, 2010).  Bruxism can be 
described as involuntary non-functional, rhythmic or spasmodic gnashing, grinding and 
clenching of teeth (not including chewing) (Dorland, 2012).  It may occur at night as a 
parasomnia (Thorpy, 2012), or during the day as sustained clenching (Lobbezoo et al., 
2013).  The mechanism that generates bruxism remains largely unknown, however, stress, 
anxiety, depression and other personal characteristics seem to have a large impact, 
particularly in relation to wake bruxism (Manfredini & Lobbezoo, 2009).  Muscle activity 
during sleep and gastroesophageal reflux have been linked with the onset of sleep bruxism 
(Miyawaki et al., 2003; Shedden Mora et al., 2012).  The masseter muscle has been found to 
be nocturnally active in many people, leading to over activity and tension throughout the jaw 
putting large forces through the TMJ and muscles of mastication.  Nocturnal masseter action 
has been reported to produce higher pain intensity including headache, tinnitus and 
stomatization (Shedden Mora et al., 2012).  Treatment of the masseter muscle could relieve 
pain and decrease tonicity in the muscle which may reduce the agonist-antagonist workload 
of other muscle of the jaw and improve muscle function (Moore, 1993). 
 
Reports that bruxism is a major predisposing factor in TMD have been argued (Carlsson, 
Egermark, & Magnusson, 2002).  A higher level of TMJ related symptoms and somatization 
can be seen in bruxers, however, recent evidence shows that pain intensity itself is not 
related to nocturnal bruxism (Shedden Mora et al., 2012).  Carlsson et al. (2002) 
investigated the progression of symptoms most likely to predict onset of TMD up to 20 years 
into the future.  Across a large population from adolescence to 35 years of age, four 
significant predictors were common.  Joint clicking was the strongest predictor, followed by 
bruxism, oral parafunctions and deep bite, suggesting that bruxism is a strong predictor.  
Sustained clenching causes significant anterior joint space reduction due to compression of 
the articular cartilage and disc which further suggests that bruxism is a predictor for TMD 
(Takenami et al., 1999).   
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7. Upper Cervical Complex and Temporomandibular Disorder 
 
Chronic TMD has been found to influence the function of the upper cervical segments and 
the same can be seen in reverse (Walczynska-Dragon & Baron, 2011).  The motion of the 
skull and neck during chewing and sustained static posture is reciprocal.   Failure of postural 
maintenance and horizontal gaze results in inequality between the head and shoulder plane 
when the bite and skull base are not even (Thomas, Dickerson, Thomas, & Davies, 2009).  
Reversely, levelness between the head and shoulder plane follows postural disturbances 
which unbalances the bite resulting in TMD (Thomas et al., 2009).  The head extends 
posteriorly as the jaw opens, and flexes as it closes, however in whiplash disorders jaw and 
neck movement decreases and only anterior posterior motion occurs at the atlanto-occipital 
joint (Thomas et al., 2009).  The mandible position may have an effect on differences in 
resting length of the muscles that attach to it (Passero, Wyman, Bell, Hirschey, & Schlosser, 
1985).  Variations in muscle length may result in compensatory changes to muscles of the 
neck, shoulders and chest altering musculoskeletal balance and leading to a forward head 
posture and raised anteriorised shoulders (Passero, Wyman, Bell, Hirschey, & Schlosser, 
1985).  Based on two reported cases Passero et al (1985) theorized that forward head 
postures created hyperactivity of cervical erector spinae, levator scapulae, upper trapezius 
and anterior vertebral neck flexors leading to increased tonicity and widespread pain. 
 
A strong association between the presentation of TMJ pain, cervical pain and headaches 
has been suggested (da Silva et al, 2013; Benoliel, et al. 2011).  TMJ headaches are 
secondary in nature and result from dysfunction within the TMJ and the muscles surrounding 
it (International Headache Society, 2013).  Both cervicogenic headaches (CGH) and TMJ 
headaches are listed as subgroups of “headache or facial pain attributed to disorders of the 
cranium, neck, eyes, ears, nose, sinuses, teeth, mouth, or other cranial facial structures” 
(International Headache Society, 2013), however this exact diagnosis can only be made 
once the patient has had resolution of the headache after treatment of the area (International 
Headache Society, 2013).  Headaches are a commonly reported symptom of TMJ disorders. 
da Silva et al. (2013) found that approximately 50% of patients who presented to a headache 
centre with chronic daily headaches had a TMJ disorder, whereas only 30% were seen in 
the general population.  Other symptoms may include jaw, ear, facial and neck pain, 
masticatory muscle pain, fatigue and muscle tightness (Evans, 1996).  TMJ pain may be 
unilateral or bilateral in nature and may refer to different regions of the head and neck, the 
same may be seen in reverse. This bidirectional referral is likely due to a convergence of 
upper cervical and trigeminal muscle afferents on second order neurons in the brainstems 
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trigeminocervical complex (Ge et al. 2004).  von Piekartz and Ludtke (2011) found that 
approximately 44% of patients suffering from CGH also had temporomandibular joint 
dysfunction.  Treatment of the TMJ in those suffering from CGH has resulted in significant 
improvement in cervical pain and headaches (von Piekartz & Ludtke, 2011; Walczynska-
Dragon & Baron, 2011).   
 
Sustained forward head posture has been reported as a precipitating factor in CGHs as it 
places strain on the upper cervical segments (Page, 2011).  It has also been reported that 
poor posture is a predisposing and maintaining factor in TMJ disorders (Nicolakis et al., 
2000). A study by De Wijer, et al. (1996) suggests that due to the prevalence of cervical 
spine disorders in groups of patients with TMD, TMD of a myogenous nature should not be 
viewed as a local disorder, but rather incorporate the entire upper quadrant to include the 
stomatognathic system, cervical spine and shoulder girdle. Subsequently, new research 
suggests that treatment of TMD can have a significant effect on reduction of spinal pain and 
improve cervical spine range of motion (Walczyńska-Dragon, Baron, Nitecka-Buchta, & 
Tkacz, 2014). 
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8. Interventions for Temporomandibular Disorders 
 
Pharmaceutical Interventions 
 
Current conventional treatments for TMD often include pharmaceutical interventions.  The 
use of non-steroidal anti-inflammatory drugs (NSAIDS) has been described in several 
studies.  Diclofenac is a well-known anti-inflammatory which can be purchased over the 
counter or in higher dosage with a prescription (Moore, 2007).  Varoli, Sato, Pita, do 
Nascimento, and Pedrazzi (2012) studied the effects of sodium diclofenac compared with a 
combination of sodium diclofenac, carisoprodol, paracetamol and caffeine against a placebo 
in a sample of 18 subjects with TMD.  A triple-blind randomized crossover method was 
utilised so all subjects experienced all treatments at different sequences.  An eleven day 
washout period followed each treatment. Subjects were diagnosed using the older 
RDC/TMD criteria which has since been replaced with the new DC/TMD version described 
by Schiffman et al. (2014).  Age ranged between 35 and 70.  Results showed that sodium 
diclofenac alone provided higher analgesic properties when compared to the combination 
and placebo.  No stage of chronicity was established which could have affected the results.  
An occlusal splint was used on each subject creating a co-intervention bias.  A study by 
Mejersjö and Wenneberg (2008) compared occlusal splint therapy and diclofenac in 29 TMJ 
osteoarthritis sufferers and found that although both splint therapy and diclofenac reduced 
TMD symptoms, diclofenac provided a more rapid improvement.  MejersjÖ and Wenneberg 
(2008) described using three 50mg sodium diclofenac tablets whereas Varoli et al. (2012) 
did not describe their dosage or whether the same dosage was given to each subject.  The 
age ranged between 36 and 76 however, evidence suggests that TMD pain diminishes after 
the age of 65 (LeResche, 1997).  Zamiri, Mousavizadeh, Tajoddini, Mohammadinezhad, and 
Aarabi (2009) found that when comparing NSAIDs to tramadol, a narcotic used to treat mild 
to severe pain, subjects experienced headaches, nausea, vomiting, drowsiness, tremor and 
vertigo with tramadol and were therefore not satisfied with its use. 
 
While the described drugs can reduce inflammation and treat the symptoms of TMD the long 
term use of such drugs can lead to peptic ulcers (Langman et al., 1994), gastrointestinal 
haemorrhage and renal toxicity (Derry & Loke, 2000) (Dionne and Berthold 2001) and should 
therefore only be taken after consulting a doctor and use should be limited to a short term 
(Derry & Loke, 2000; Dionne and Berthold 2001).  .  Di Rienzo Businco, Di Rienzo Businco, 
D'Emilia, Lauriello, and Coen Tirelli (2004) compared the use of oral diclofenac with topical 
administration and found that there was no significant difference between the two groups 
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suggesting that diclofenac can be administered topically to counteract the gastrointestinal 
issues.   
 
Further treatments include cortisone injections which, while these injections can reduce 
inflammation, they do not address the cause of the problem and are therefore only a 
temporary measure (Stoustrup et al., 2013).   
 
Occlusal Splint Therapy 
 
Non-pharmacological treatments such as orthopaedic appliances, also known as occlusal 
splints and night guards, have shown some efficacy in relieving TMD pain (Ebrahim et al., 
2012).  However, these appliances, when compared with other treatment modalities have 
been found to be no more or less effective than acupuncture, bite plates, stress 
management and jaw exercises (Al‐Ani, Davies, Gray, Sloan, & Glenny, 2004).  It has also 
been reported that they are uncomfortable to wear and disturb sleep, therefore lowering 
patient adherence and satisfaction (Pierson, 2011).  Splints can be used as night guards for 
those with bruxism to protect the teeth and TMJ.  Alammari, Al-Rafah, and Alkhiary (2013) 
studied the effects of occlusal splints on 16 symptomatic patients with bruxism.  Although the 
condition is more common in females all participants in this study were male.  It is not known 
whether gender differences in the response to treatment of the condition exist, and results 
generated in a solely male population may not be generalizable to females. Furthermore, the 
use of occlusal splints may reduce tooth wear but fail to address underlying causes of TMD, 
for example hormonal influences, as suggested by Turner et al. (2011).  The study 
compared two types of splints thickness based on a conventional method or divine 
proportion method for rest vertical dimensions of the appliance.  They found that a plane 
occlusal stabilization splint with occlusal opening can interrupt the biofeedback mechanism 
that leads to bruxism and relieves symptoms of TMD.  The divine proportion method of splint 
therapy was considered the most reliable for those with TMD.   
 
Invasive procedures 
 
Arthrocentesis is a minimally invasive therapy performed under local anaesthetic where fluid 
is aspirated from a joint space and a therapeutic substance is injected (Brown, 1969). A 
single cohort study by Tvrdy, Heinz, Zapletalova, Pink, and Michl (2014) investigated the 
effects of arthrocentesis in combination with occlusal splints on subjects with nonreducing 
temporomandibular joint disk displacement.  144 subjects were investigated over a 6 year 
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period.  The sample was predominantly women (90.3%), however the results found that 
85.7% of men had a positive treatment outcome while only 66.2% of women had a positive 
outcome.  Overall 68.1% had a positive treatment effect.  Follow up data was recorded 3 
months post treatment to provide longer term evidence of treatment effect with positive 
results.  The study does not look at the individual effects of arthrocentesis compared with 
occlusal splints, yet it states that the two modalities combined provide a greater effect than 
their use in isolation. However, there is no control to compare it against. 
 
Occlusal adjustment is the adjustment of the biting surface of teeth when the joint between 
the lower mandible and base of the skull are not aligned appropriately resulting in TMD (Koh 
& Robinson, 2003).  It has been used in both prevention and relief of TMD; however, Koh 
and Robinson (2003) found through systematic review that there is an absence of evidence 
in randomly controlled trials that occlusal adjustments are successful in treating TMD.  
Occlusal adjustments are invasive and permanent surgical procedures and therefore should 
not be recommended to patients when there is so little evidence to suggest their success.  
 
Patient Education and Self Care. 
 
Nicolakis et al. (2002) investigated the effects of exercise therapy for myofascial pain 
dysfunction syndrome in TMD.  This before-after study design aimed to examine the 
effectiveness of massage, active and passive jaw movement with isometric contraction, 
correction of body posture and relaxation techniques as well as self-management on a group 
of 20 people presenting with chronic myogenous temporomandibular joint disorder.  They 
conceptualized that stress and poor neck function are highly related to TMD and need to be 
addressed to achieve a positive result.  Measurements were taken at baseline, immediately 
pre- and post-treatment and six months post-treatment.  Measures included visual analogue 
scales of 100 mm for pain and daily life impairment, incisal edge opening using a slide 
gauge in mm, and perceived improvement of joint pain and function using a seven-point 
scale.  Pain and incisal edge clearance improved in 95% of patients and 90% reported an 
improvement in perceived impairment. Whilst the rationale and hypotheses for this study are 
clear, there are some reporting issues, for example lack of reference to any ethical approval 
for the study.  Variations in baseline wait time (5 – 69 days) and treatment time (25 – 88 
days) were addressed as a limitation as this could have caused timing bias where if the 
intervention is over a long period of time, maturation may have caused the change, or if it’s a 
short period of time it may not be sufficient to notice and affect (Krishna, Maithreyi, & 
Surapaneni, 2010).  The before-after design reduces drop-out rates as everyone receives 
treatment.  Alternatively, having no control group increases difficulty in determining whether 
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results arose from the treatment alone (Law et al., 1998).  Each patient was treated at least 
5 times or more depending on the patient.  Differences occurred in the type of treatment 
patients received which may affect generalization and external validity.    
 
Manual Therapy Techniques for TMD 
 
Non-invasive and reversible methods of TMD treatment are becoming more favorable with 
the shift of current research from mechanical aetiology to biopsychosocial and hormonal 
factors (Turner et al., 2011).  Osteopathic research into efficacy of specific techniques such 
as joint articulation, soft tissue massage and functional osteopathy are particularly rare 
whereas high velocity low amplitude thrust, muscle energy technique, visceral and cranial 
techniques have been well studied in recent years (Schamroth, 2014).  Osteopaths are 
primary healthcare providers who use a wide range of manual therapy treatments to provide 
relief for physical structure and functional disorders (Osteopathic Council of New Zealand, 
2014).  The concept of osteopathy was first presented by Andrew Taylor Still in 1874 as a 
way of treating the body by improving its natural functions as opposed to altering the body 
with external interventions (Parsons & Marcer, 2006).  Until recent years there has been little 
research investigating the effects of osteopathic manual therapy (OMT) and specific 
osteopathic techniques.  Clinically relevant research into the effects of specific techniques 
rather than OMT are essential for the growth of the osteopathic profession by supporting the 
day to day utilization of techniques in clinical practice and expanding the knowledge base of 
the profession (Schamroth, 2014).  Kalamir, Pollard, Vitiello, and Bonello (2007) suggest that 
manual therapy may be a useful and cost effective method for treating TMD with less side 
effects than dental treatment.  Seven studies investigating the use of osteopathy and specific 
manual therapy techniques for temporomandibular joint disorders were derived using 
EBSCO, Pubmed, Science direct and Google Scholar.  Keywords were temporomandibular 
joint dysfunction, craniomandibular, osteopathic treatment and manual therapy.  
 
Cuccia, Caradonna, Annunziata, and Caradonna (2010) compared the effects of osteopathic 
manual therapy (OMT) with conventional conservative therapy on adults (n=50) aged 18 to 
50 suffering from chronic TMD.  In this case, control study participants were randomly 
divided into an OMT group and received treatment by an osteopath, the other group 
received conventional conservative therapy (CCT) by a gnathologist.  Participants were 
assessed for pain intensity, maximal mouth opening (MMO), range of motion of head around 
lateral axis and temporomandibular index (TMI).  Measurements were taken at baseline, 24 
weeks and 32 weeks.  The most significant changes were observed in the OMT group. 
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The study aimed to reduce pain and restriction of muscles and ligaments and retrain 
involuntary neuromuscular control of posture and balance.  Assessment methods for pain 
and range of motion in the cervical spine and TMJ are clearly described, however, 
techniques used in either group were not explained.  The study did not specify whether it 
was directed at discal, myogenous or arthritic TMD which may alter results.  Treatment was 
given every second week for six months.  The time-frame and break between treatments 
appears quite long in comparison to other studies; why these timings were chosen is not 
stated.  The sample size is small which is helpful when testing new hypotheses however 
there are often limitations when interpreting results and providing precision.  The use of non-
steroidal anti-inflammatory drugs (14:6) and muscle relaxants (8:1) were more prevalent in 
the CCT group and their use was not restricted.  Taking medication creates an opportunity 
for co-intervention bias and inaccuracy in results.  Furthermore, using a different practitioner 
for each group can create therapist bias as a more motivated or positive practitioner could 
lead to better results in a group (Law, Stewart, Pollock, Letts, Bosch, & Westmorland, 1998).  
Steps need to be taken to ensure inter-practitioner reliability.  Identification of limitations was 
absent. 
 
Two small studies were found investigating the effect of Muscle Energy Technique (MET) on 
TMD.  Rajadurai (2011) aimed to increase maximal mouth opening and reduce pain in 40 
participants with acute and sub-acute discal or myogenous TMD.  A compact age range of 
between 20 – 30 years represented a smaller section of the population.  Measurements 
were taken using a clear plastic ruler for opening range and pain was measured using the 
VAS.  Results showed a decrease in VAS scores and increased MMO over the 5 weeks.  .  
The paper claims to be a randomized clinical trial however the only randomization mentioned 
was the random sample of participants who had been diagnosed by dentists using clinical 
findings and imaging.  There was only one clinical group that subjects were assigned to 
which makes it harder to distinguish where the results came from and makes it more likely a 
single cohort design. There were numerous resources used in the introduction, however they 
are mostly old (pre-dating 2000).  The mechanisms of MET are weakly described in the 
discussion section as stimulation of the golgi tendon organs and muscle spindles to reduce 
excessive activity.  It did not describe where the MMO measurements were taken from or the 
accuracy of the measurements.  Although the study was poorly administered it had a good 
hypothesis and the results, although not entirely credible, were positive.  
 
Hopkins (2010) used a single system design to investigate the effects of MET on TMJ 
opening range, pain and disability perception on 12 subjects over a 10 week period.  As this 
was a small sample size with no blinded control group the risk of response bias increased as 
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participants may be more inclined to try to show positive results.  Because participants were 
their own control a baseline of 5 weeks was recorded followed by 5 weeks of intervention.  
The mouth opening range only had two baseline data points but still succeeded in reaching 
statistical significance of P <0.001 at end of intervention.  A clear ruler was used to measure 
mouth opening range, of which 3 measurements were taken and the number averaged.  This 
helps increase administrator reliability and reduces variation in measurements.  VAS was 
used for pain intensity and the temporomandibular disability index was used for measuring 
disability.  Subjects were not distinguished into myogenous, discal or arthritic presentations 
so it is not clear if their condition was related to their outcome.  Including demographic data 
could have provided a more in depth picture in a small sample.  Overall results were positive 
and although the sample size was smaller it appeared to be a more reliable indication than 
the study by Rajadurai (2011) 
 
A randomized controlled trial by Kalamir, Bonello, Graham, Vitiello, and Pollard (2012) 
containing 93 participants investigated the efficacy of intra-oral techniques such as trigger 
point release of the temporalis, medial and lateral pterygoid muscles, and the 
sphenopalantine ganglion for parasympathetic manipulation for chiropractic treatment of 
TMD.  It also investigated the efficacy of education and self-care techniques including a 
post-isometric relaxation technique and a cross pressure chewing technique.  Myofascial 
trigger points are hyperirritable, sensitive, palpable nodules within taut bands of skeletal 
muscle or fascia (Lavelle, Lavelle, & Smith, 2007).  Trigger points are often present in the 
TMJ, head or neck upon palpation and may cause numerous sensory, motor, neurologic, 
and autonomic symptoms (Lavelle et al., 2007; Simons, Travell, & Simons, 1999). Key 
clinical signs and symptoms include restricted range of motion, referred pain, muscle 
weakness and increased stretch sensitivity (Lavelle et al., 2007).  Muscle inhibition and 
ischemic compression have been found to be effective in reducing pain and improving 
strength and mobility in upper and lower trapezius muscle, levator scapulae muscle, splenius 
cervicis muscle, supraspinatus and infraspinatus muscle trigger points (Cagnie et al., 2013).  
In the TMJ study participants were divided into 3 groups, a control group, a treatment (IMT) 
group and a treatment plus self-care (IMTESC) group.  The results suggested that both 
treatment groups improved significantly more than the control group, however the difference 
between the IMTESC and IMT groups was not statistically significant.  The techniques 
investigated were more commonly associated with osteopathic techniques than chiropractic 
("Intraoral Manipulation and Jaw Exercises Shown to Be of Benefit in Temporomandibular 
Joint Disorder," 2012).  The research diagnostic criteria (RDC/TMD) was administered for 
classification of myogenous type; those with signs of internal disc derangement and arthritis 
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were excluded which highlights a need to investigate this type of intervention on other TMD 
types.  A block design randomization was used to lessen the impact of variation. 
 
The study by Kalamir, Bonello, Graham, Vitiello, and Pollard (2012) indicates that ROM, 
clicking sounds and palpatory pain findings have limited measurement reliability whereas 
clenching pain, maximal opening pain and resting pain were thought to be more reliable 
using the global perceived change scale (GPCS).  However, use of a self-reporting scale 
such as the GPCS can enable opportunity for memory bias (Grøvle et al., 2014; Law et al., 
1998).  Three groups allowed for two interventions to be studied.  The control group received 
no treatment over a 6-month period where their symptoms were recorded and monitored.  
Lack of treatment can potentially discourage participants and increase drop-out rate, 
particularly if their symptoms of TMD worsen.  No problems with drop out were noted in this 
case.  Another difficulty with interpreting the results was that the IMTESC group contained 
disproportionally more males than females compared with other groups. The effect of gender 
on the results independently of group assignment was unknown. Control of exercise 
adherence was not mentioned and the self-administration of techniques may have 
influenced the IMTESC group’s result.  
 
As mentioned previously, sustained clenching and TMD reduces anterior joint space in the 
TMD creating compression of the intra-articular disc and condyle (Takenami et al., 1999).  
Joint distraction and articulation enables decompression of the articular cartilage, reducing 
wear and tear and enabling healing to occur by gently creating space in the joint.  Joint 
distraction has been shown to be effective in the management of osteoarthritis of the knee 
and ankle (Intema et al., 2011).    
 
In the case of articular disc derangement, the use of joint distraction with medial and lateral 
glide should facilitate the movement of the disc into the correct position as well as increasing 
fluid drainage out of the joint and reperfusion of the area ,reducing tension in associated 
tissues and increasing range of motion in the joint (Kirk Jr & Calabrese, 1989). Studies have 
found that condylar position has a significant effect on TMD.  Weinberg (1979) suggests that 
limited opening range and pain may be associated with a posterior positioning of the condyle 
while Robinson de Senna, Marques, França, Ramos-Jorge, and Pereira (2009) have found 
that pain is caused by condylar excursion.  Conversely Juca, Galdames, and Guimarães 
(2009) found that condylar position had no significant effect on mouth opening range.  
Studies investigating the effects of joint distraction and articulation in manual therapy are 
scarce (Schamroth, 2014) therefore a study investigating the effects of specific techniques 
such as articulation on patients suffering from TMD is needed. 
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The use of joint distraction for TMJ mobilization was has been described in two studies.  
Dommerholt and Huijbregts (2010) describe the technique used in a case report and noted 
that the patient’s symptoms improved through increasing TMJ mobility, stability and 
positioning, however, very little more information is included.  A much larger study utilizing 
the techniques along with a systematic exercise prescription was conducted by Kirk and 
Calabrese (1989).  This study investigated the effects of Rocabados manual joint distraction 
and disc recapture techniques along with Rocabados 6x6x6 exercise programme on 68 
patients with internal disc derangement of the TMJ.  No myogenous or arthritic type 
presentations were included.  The historical study was conducted over a 12-month period 
from 1983 – 1984 which highlights the need for more recent research. 
 
The study did not clearly outline what the outcome measures were but pain and joint clicking 
were both mentioned in the results.  Kalamir et al. (2012) however, describes joint clicking 
sounds as an unreliable outcome measure.  Pain was reported to decrease across all 
groups but clicking remained in many of the subjects.  Only those who had acceptable 
clinical diagnosis of TMJ disc displacement and no subjective complaints, were included 
unless there was a confirmed diagnosis by a surgeon.  Patients were only included if they 
had preauricular or deep ear pain, those with only masticatory muscle pain were excluded.  
Pain from the TMJ can present at multiple regions in the orofacial area, therefore a large 
portion of adequate subjects may have been excluded (Bagis et al., 2012; Chole & Parker, 
1992).  A large number of pain relief interventions were utilized including ultrasound, 
phonophoresis, transcutaneous electrical nerve stimulation, acustimulation, ice, heat and 
massage.  Use of other interventions creates co-intervention bias and inaccurate results may 
occur, particularly when using pain as an outcome measure (Krishna et al., 2010).  Patients 
reported whether their pain intensity had changed but not with a valid and reliable tool for 
measuring pain.  No mention was made of the frequency and patient adherence to exercise. 
Subjects with mild to moderate symptoms had predominantly good results, however, very 
few of those with severe locking improve.  Those with the worst outcomes had clicking on 
mediolateral movement with the disc displaced more medially than anteriorly.  
 
A case report by Pierson (2011) studied the use of massage therapy and self-care routine on 
a 26 year old female with chronic TMD including stress, poor posture and bruxism.  The 
patient received ten, 45-minute treatments over five weeks using gentle massage, intra-oral 
techniques and myofascial work to the neck, face and head.  The study also investigated the 
relationship between stress, pain and TMD as well as posture and TMD.  Six outcome 
measures were used and results were positive.  The patient’s daily journal indicated that 
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massage therapy decreased stress levels and pain and also showed that stress was often a 
contributing factor to TMJ pain.  Measurements were taken at baseline, midway and post 
treatment.  The study indicates use of treatment in myogenous and discal TMD. 
 
The amount of detail conveyed in the report is immense and the investigation into the 
participant’s lifestyle enables better understanding of the factors that contribute to or 
maintain her TMD.  Deep reflection of processes and in-depth descriptions of mechanisms, 
treatments and outcome measures enable a greater chance of reproducing the techniques.  
The study showed strong correlation between stress and TMJ pain and discussed how 
changes in cortisol, dopamine and serotonin levels after massage can decrease stress and 
therefore decrease pain. 
 
Limitations of the study identified the three knuckle test for orthopaedic testing as unreliable; 
the author suggests using a ruler or a geniometer for better opening measurement and use 
of better pain questionnaires.  Kalamir et al (2010) suggests that palpatory findings and 
ROM, as used in this case, have limited reliability which could decrease the accuracy of the 
study.  
 
A case report enables greater opportunity to summarize and discuss findings in a detailed 
way due to further information being known about the patient.  However, case reports are 
limited in that they only surround the experience of one participant and have no comparison.  
More participants would create a more generalized view and show variation because no one 
person is the same across a population and variation in results shows this.  There is a higher 
possibility that the effects seen in this study will not be seen in other people and this limits 
the validity and effectiveness of the methods. 
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9. Methodology  
 
Randomized controlled trials (RCT) are regarded as the gold standard for experimental 
research, however, they are not always feasible for use in a in a small profession such as 
osteopathy, or when participant numbers are not high enough to reach statistical significance 
(Sanders, 2003).  A single system research design (SSRD) is a quasi-experimental design 
which follows a single person or system over a period of time with that person acting as their 
own control (Carter, Lubinsky, & Domholdt, 2013).  SSRDs seek to ascertain whether a 
variable being studied changed after an intervention was introduced and whether there is 
evidence to suggest that it was actually the intervention that resulted in the change (Bloom, 
Fischer & Orme, 2006).   This design is very useful for osteopathic research as it is a cost 
effective and simple way to investigate responses to interventions as a group or individual 
(Sanders, 2003). 
 
SSRD’s, while excellent for gathering demographic data on a small group, have some 
limitations.  RCTs compare results of the intervention group with results from a control 
group, however a lack of a control group may decrease the strength of the results.  An RCT 
may be a double blinded trial which means keeping participants, investigators or assessors 
unaware of the intervention to reduce influence from that knowledge and information bias 
(Schulz & Grimes, 2002).  No control group makes room for bias and it is not always clear 
whether the results are actually from the intervention.  Response bias occurs when the 
subject has no control resulting in the participant becoming more agreeable or wanting to 
please the researcher resulting in an overestimation or underestimation of true population 
parameters (Lavrakas, 2008).  An SSRD needs to establish a stable baseline phase before 
introducing an intervention, data needs to predict a pattern before entering into the next 
phase.  Wide fluctuations in data make it difficult to ascertain a pattern and detect change 
(Bloom, Fischer & Orme, 2006). 
 
10. Summary 
 
The effects of TMD and chronic pain on quality of life are immense and adequate treatments 
for TMD are limited leaving those inflicted to endure the pain and disability caused the by the 
disorder. TMD incorporates a variety of pathological characteristics to the joints and muscles 
therefore a sound understanding of the predisposing and maintaining characteristics of this 
condition is important for effective management.  Introduction of an effective manual therapy 
treatment has the potential to ease the burden of those suffering from TMD.  There is a lack 
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of research into the effects of distraction and articulation with medial and lateral glide on the 
TMJ, yet the technique is often performed by manual therapists.  Subsequently, research 
into the effects of the techniques is needed.  The combination of the two intra-oral 
techniques could be integrated into future osteopathic practice for effective treatment for 
TMD. 
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ABSTRACT 
 
Background:  Temporomandibular Disorder (TMD) will be experienced by many of the 
population with symptoms ranging from mild to severe.  The management of chronic TMD 
can be challenging as well as costly.  Manual therapies like osteopathy may offer an 
effective intervention for TMD. 
Objective: This single system research design aimed to investigate the effectiveness of 
specific intra-oral osteopathic techniques in improving pain quality, intensity, mouth opening 
range and disability in TMD.  
Methods: Ten participants (7 female) aged 16 to 43 (mean 29.2 years) with TMD pain from 
1–12 years duration (mean 3.23 years) completed this 12-week study.  Data was collected 
bi-weekly over 3-week baseline, 6-week intervention, and 3-week follow up phases.  
Results: Improvements from baseline to end of intervention and follow up were noted for 
McGill Pain Questionnaire (MPQSF) sensory pain (pre 10.9±5.98 and post 5.2±6; P< 
0.0001), Visual Analogue Scale at rest (VAS-R; 2.9±1.5 and 1.2±1.4; P<0.0001) and 
mastication (VAS-M; 6.2±1.9 and 2.7±2.5; P<0.00001), and TMD Disability Index (TMDI) 
scores (11±4.9; P<0.0001).  Change in MPQ-SF affective scores reached borderline 
significance (P<0.08).  No significant changes were observed in Maximal Mouth Opening 
(MMO).  Post hoc analyses showed changes occurred early in treatment and were sustained 
to follow-up for VAS-M, VAS-R, MPQSF, and TMDI. 
Conclusion: Reduction of self-reported pain quality, intensity and disability from baseline 
occurred following treatment with intra-oral osteopathic techniques.  The results of this 
preliminary study suggest that the osteopathic management of chronic TMD incorporating 
intra-oral techniques may be effective. 
 
 
Keywords: TMJ pain; TMD management; Osteopathic medicine; Intra-Oral technique; 
chronic pain. 
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1. INTRODUCTION 
 
Chronic pain is a widespread problem and management of chronic conditions can be 
challenging (Larrabee, 2011).  An estimated 20 – 25% of primary care patients worldwide 
will present with chronic pain (Gureje, Von Korff, Simon, & Gater, 1998), with head and neck 
presentations accounting for a large number of cases (Andersson, Ejlertsson, Leden, & 
Rosenberg, 1993; Lund, Lavigne, Dubner, & Sessle, 2001).  Temporomandibular disorder 
(TMD), defined as “functional disturbance of the masticatory system” (Okeson, 2007), is a 
broad term encompassing a range of conditions affecting the temporomandibular joint (TMJ).  
It is produced by myogenous or muscular influences (45.3%), disc displacements (41.1%) 
and arthrogenic disorders (30.1%), with many TMD presentations being a combination of 
these (Manfredini et al., 2011).  Among people with TMD, myofascial pain with or without 
opening limitation is the most common diagnosis (Manfredini et al., 2011).  Associated 
symptoms of joint and muscular pain, joint sounds such as clicking and crepitus, locking, 
headache and impaired range of motion have been reported (Bagis, Ayaz, Turgut, Durkan, & 
Özcan, 2012; Merskey, 1986).  Furthermore, aural symptoms such as otalgia, tinnitus, 
dizziness and vertigo can occur (Chole & Parker, 1992).  
 
Bruxism, microtrauma and psychosocial factors such as stress and anxiety are commonly 
associated with the onset of TMD (Ciancaglini, Gherlone, & Radaelli, 2001; Zhang, Ma, Gao, 
Gu, & Fu, 1999).  Other possible predisposing factors include poor posture, breathing 
pattern disorders, genetics, sleep disturbance and pain catastrophizing (Buenaver et al., 
2012; CliftonSmith & Rowley, 2011; Smith et al., 2013).  Due to the significant 
biopsychosocial nature of TMD, treatments that are non-invasive and non-surgical are often 
regarded favourably (Suvinen, Reade, Kemppainen, Könönen, & Dworkin, 2005), and may 
represent a viable, low cost approach to treatment without exposure to invasive surgeries 
(Kalamir, Pollard, Vitiello, & Bonello, 2007). 
 
In New Zealand, people with TMD symptoms usually present to their general practitioner for 
referral or directly to a dentist for TMD symptom management.  Typical management 
includes jaw exercises, bite splint therapy, medications such as analgesics, non-steroidal 
anti-inflammatory drugs and tricyclic antidepressants, and physiotherapy modalities including 
acupuncture (ACC Review 55, 2014).  Knowledge and understanding of basic pain 
mechanisms, TMD experience and evidence-based treatment for TMD is generally low 
among practicing dentists, with only 48% of a sample in Australia scoring correctly on TMD 
pain knowledge tests (Borromeo & Trinca, 2012).  Treatments using cognitive behavioural 
therapy, mindfulness (Liu et al., 2012), postural retraining (Carlson, Bertrand, Ehrlich, 
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Maxwell, & Burton, 2001), exercise (Nicolakis et al., 2002) and spinal manipulation 
(Jayaseelan & Tow, 2014) have been investigated with varying results.Manual therapy 
techniques may provide a useful treatment alternative, despite this few patients will seek or 
be referred for manual or other therapy.   
 
Osteopathic manual therapy (OMT) incorporates a range of manual therapy treatments for 
relief of TMD.  Research investigating the efficacy of OMT and specific osteopathic 
techniques has been scarce until recently.  Research into efficacy of some specific 
techniques comprising high velocity low amplitude thrust, muscle energy technique, visceral 
and cranial techniques, have been well studied in recent years, whereas techniques such as 
joint articulation, soft tissue and functional are particularly rare (Schamroth, 2014).  Recent 
studies have utilised muscle energy technique for the treatment of TMD with positive results 
(Hopkins, 2010; Rajadurai, 2011).  Research into the effectiveness of specific osteopathic 
techniques for TMD is limited, therefore investigations into their effectiveness may help to 
guide practitioners in their appropriate selection of interventions for patients suffering from 
this condition.  The aim of the current study was to investigate the effectiveness of specific 
intra-oral osteopathic techniques in patients suffering from chronic TMD so that these 
techniques can be used with confidence in clinical practice. 
 
 
2. METHODS 
 
A single system design was employed to examine the effects of intra-oral osteopathic 
treatment on temporomandibular pain, mouth opening range and disability over a 12-week 
period.  Data were collected twice weekly over a 3-week baseline period, 6-week 
intervention phase and 3-week follow-up.  The study was conducted in a room on the 
premises of Unitec Auckland, Carrington Campus and at participants’ homes.  The study 
was approved by the institutional research ethics committee (UREC Approval 2013-1054 
and ACTRN12614001301651) [See Appendix]. 
 
 
2.1   Study Sample 
 
Participants were recruited between July and September 2014 via advertisements on flyers 
at Unitec Institute of Technology Osteopathy Clinic, Facebook, one local paper, Auckland 
Council Intranet, and by referral of patients from clinical students and through word of 
mouth.  A sample size of 10 was determined using G*Power 3 (Faul and Erdfelder, 2007) 
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according to effect sizes of similar cohort TMJ studies (Hopkins, 2010; Kalamir, Pollard, 
Vitiello & Bonello, 2010) using the most conservative effect size previously reported (0.9), an 
alpha of 0.5, power of 0.8, and assuming a one-tailed paired t-test.  Using a two-tailed test 
and the same parameters, 10 participants would be sufficient to detect an effect size of 1.0, 
equivalent to a change in VAS of 1.9 – 2.0 mm (Hopkins, 2010) (Kalamir, Pollard, Vitiello, & 
Bonello, 2010). 
 
Inclusion criteria were history of current and persistent pain in the temporomandibular region 
when chewing or clenching and general pain at rest; clinical evidence of restricted range of 
motion opening, lateral glide, protrusion and/or retraction found through physical 
examination.  An age range of 18 – 65 years of age was set initially, however, the lower limit 
was broadened to 16 years prior to the study, with ethics approval of the amendment, due to 
difficulty in recruiting eligible participants combined with interest from a 16 year old who fitted 
all other criteria.  Patients with clinical or radiographical evidence of osteoporosis, history of 
malignancy in the skull in the last 5 years, history of fractures or dislocation of the mandible, 
severe and ongoing jaw locking and those currently under orthodontic or other TMD 
treatment were ineligible.  Prospective participants were primarily contacted by email or text 
with an information sheet and questionnaire to determine eligibility and were invited to attend 
a 10 – 15 minute consultation to confirm eligibility, be informed of the study protocol and give 
verbal and written consent. [See Appendices].  To establish possible presence of bruxism, 
participants were also asked if they regularly clenched or ground their teeth, experienced 
headaches, stress, anxiety, depression or other biopsychosocial or musculoskeletal 
conditions. 
  
 
2.2   Outcome Measures 
 
McGill Pain Questionnaire – Short Form (MPQSF)  
The MPQSF requires participants to select appropriate pain descriptors from a selection of 
fifteen (Melzack & Katz, 2001).  Eleven sensory descriptors assess nociceptive pain and four 
affective descriptors measure the emotional impact of nociceptive pain experience.  
Descriptors are rated from 0 - not applicable, 1 - mild, 2 – moderate, 3 – severe with a total 
of 45 points.  As a measurement of pain the MPQSF has demonstrated high reliability 
(McMahon, Koltzenburg, Tracey, & Turk, 2013).  Test-retest reliability between 0.76 - 0.95.  
No literature could be found to identify what change in scores would constitute a MCID, 
however the Norwegian version of the MPQSF suggests a MCID of more than 5 for 
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combined scores, 3.67 for sensory and 1.33 for affective (Hawker, Mian, Kendzerska, & 
French, 2011). 
 
Visual Analogue Scales – Resting and Mastication (VAS-R/M)  
Participants rated intensity of their most recent resting and mastication pain by placing a 
mark on a 100 mm horizontal line ranked between No Pain and Worst Possible Pain.  A ruler 
was used to measure the VAS in millimetres.  Participants were allowed to compare their 
scores with the previous scores recorded.  MCID for VAS pain intensity in sub-acute and 
chronic patients has been reported at 20mm (Ostelo & de Vet, 2005) 
 
Maximum Mouth Opening (MMO) 
Mouth opening range was measured using a 15cm clear ruler.  Participants were instructed 
to measure from the centre of the mouth the distance from upper central incisor to lower 
central incisor, opening the mouth as far as is comfortable. Self-measurements were 
undertaken due to time and travel constraints of participants.  Beltran-Alacreu, Lopez-de-
Uralde-Villanueva, Paris-Alemany, Angulo-Diaz-Parreno, and La Touche (2014) found that 
intra-rater and inter-rater reliability when tested among two raters was high for maximal 
mouth opening measurements (inter-rater, ICC = 0.95 − 0.96; intra-rater, ICC = 0.95 − 0.96).  
A MCID of 5mm for MMO has been recognised. (Kropmans, Dijkstra, Stegenga, Stewart, & 
De Bont, 1999). 
 
Disability Index (TMDI) 
The TMD Disability Index consists of 10 questions regarding disability associated with TMD 
with a total score of 40.  Each question is scored from 0 to 4, increasing with severity.  
Higher scores represent greater levels of disability, scores ≥30 represent high disability, 20 –  
30 moderate disability, 10 – 20 slight disability and <10 minimal disability (Steigerwald & 
Maher, 1997). No MCID has been reported. 
 
 
2.3   Procedure 
 
Participants attended their first appointment at an osteopathy clinic linked to the academic 
institution where the study took place.  Outcome measures were recorded and instruments 
provided to continue self-measurement of baseline data over three weeks via email.  
 
Participants received six treatments during the 6-week intervention phase.  Each session of 
the intervention phase began with a physical examination of the TMJ by a supervised final-
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year osteopathy student practitioner, which included observation, motion testing of the TMJ, 
MMO measurement, palpation of tissue texture of the maxillary, mandibular and temporal 
regions and any related pain responses such as trigger points.  Manual Therapy treatment 
was applied for 10 – 15 minutes bilaterally with patients lying supine.  Muscle inhibition was 
applied by placing gentle pressure to specific points intra-orally at temporalis, masseter and 
medial and lateral pterygoids.  A gentle distraction, based on the technique used by Kirk and 
Calabrese (1989), was then applied to the TMJ.  The patient was asked to open their mouth 
slightly.  While wearing a glove the practitioner, using the contralateral hand to the side 
being treated, placed the anterior aspect of the thumb on the superior aspect of the inferior 
row of teeth while the index finger lightly held the mandible.  Distraction was applied by ulnar 
deviation of the wrist incorporating articulation (passive joint mobilisation) into restricted 
planes of movement anterior, medial and/or laterally.  All patients received the same 
intervention with minimal variability depending on findings in tissue texture and laterality.  
Following treatment MMO was again recorded and participants recorded their VAS-R/M, 
MPQ-SF and disability scores.  Participants also provided midweek measures via email or 
paper recording sheet.   
 
 
2.4   Data analysis  
 
Raw data were compiled, checked for errors and manipulated using Microsoft Excel version 
2003.  Statistical data were analysed using SPSS 22 [IBM, Armonk NY].  Individual and 
grouped data were analysed.  Intervention phase data were grouped as three 2-week 
periods for data analysis.  Change in outcome measure from baseline to end of intervention 
phase and follow-up phase were analysed using paired t-tests and repeated measure 
analysis of variance (ANOVA).  A level of significance (P < 0.05) was considered statistically 
significant.  Assumptions of normality for variables was explored by analysing values of 
skewness and kurtosis with their standard errors and by completing Kolmogorov-Smirnov 
and Shapiro-Wilk tests as suggested by Field (2009).  Tests for equality of variance and 
sphericity assumptions were also applied for t-tests and ANOVAs, and Mauchley’s or 
Greenhouse-Geisser corrections applied when appropriate.  Pairwise comparisons for post 
hoc analysis were investigated across all time points. 
 
Cohen’s d standard response means (SRM) formulae were used to calculate effect sizes by 
taking the difference in the means between baseline, end of intervention and follow-up 
divided by the mean change in SD of the group (Wu, Chuang, Lin, & Hong, 2011).  Effect 
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sizes of >.80 were regarded as large, ±.50 as medium, ±.20 as small, and <0.2 as trivial 
(Hopkins, 2002) 
 
In order to aid interpretation of changes following treatment, reliability for each variable was 
assessed from six baseline measurements.  Intraclass correlation co-efficients and 95% 
confidence intervals were calculated.  The ICCs were interpreted using the guidelines of 
Hopkins (2002).  Standard error of measurement was determined using the formula (SEM = 
SD • (1− ICC ) and minimum detectable change was measured using the formula (MDC = 
1.96 x√ 2xSEM) (Wu et al., 2011).   
 
 
3 RESULTS 
 
3.1    Participants 
 
Participants (n=13) were recruited for the study.  Three participants withdrew from the study 
due to time constraints and inability to attend appointments and return data (Figure 1).  Data 
from 10 participants (n=3 males, n=7 females) were included in analyses; their baseline 
characteristics and symptoms are shown in Table 1.  For MPQSF two participants selected 
no affective words, therefore affective data was analysed as a cohort of eight which 
positively altered the results.  Individual data and associated maintaining factors for TMD 
have been recorded to look for any underlying patterns in the data.  Age ranged from 16 to 
43 [mean (SD); 29 (8) years].  Chronic presentations ranged from 1 to 12 years duration [3.2 
(3.4) years].  Bruxism was highly prevalent among participants (n = 7) and many had 
underlying issues with stress, anxiety and depression.  The most common presentation was 
of a muscular nature, followed closely by discal.  One participant had joint degeneration (ID 
3) and another had severe referred pain from nerve compression (ID 7; Table 1).  Those 
who reported poorer sleep also experienced bruxism, increased biopsychosocial issues and 
generally reported less overall improvement (IDs 1, 3, 6, 7).   
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Figure 1: Participant recruitment 
 
Table 1.  Participant demographic and supplementary data.   
 Age Gender Onset 
(y+m) 
Bruxism BioPS Sleep 
Trouble 
Type 
1 34 Male 2 Y DA Y M 
2 16 Female 2 Y  N D 
3 40 Male 12 Y  Y DA 
4 30 Female 1.8 Y D N M 
5 24 Female 2.5 N S N M 
6 23 Female 1 Y DA Y M 
7 31 Female 4 Y AS Y MN 
8 22 Female 5 Y S N MD 
9 43 Male 1 N  N MD 
10 29 Female 1 N S N MD 
 
Abbreviations as follows: BioPS: Biopsychosocial –   D: Depression, A:  Anxiety and S:  Stress. Type: M: 
Muscular; D:Discal; A: Arthritic, N: Nerve.  Y+M: years and months. 
 
41 
 
3.2 Individual Analysis 
 
Almost all participants improved greater than previously defined MCIDs for nearly all 
outcome variables (Table 2).  For three outcome variables (MPQSF-A, VAS-R, MMO) four of 
ten participants improved beyond MCID, though six participants failed to improve more than 
previously defined MCID of 20mm (Ostelo & de Vet, 2005), five of these scored pain levels 
less than 20mm at baseline (table 2).    
 
Two participants were consistent non-responders through many of the outcome variables (ID 
3; ID 7).  ID 3, who presented with joint degeneration, improved but not to the level of the 
MCID for MPQSF-S, and worsened for MMO and TMDI.  Similarly, Participant ID 7, who 
presented with severe nerve pain, failed to improve to MCID in MPQSF-A, VAS-R and VAS-
M.   
 
Table 2. Numbers of responders, non-responders and negative responders at follow up 
 Responders 
4 weeks 
Non-responders 
4 weeks 
Negative responders 
4 weeks 
MPQSF – S 7 3 - 
MPQSF – A 4 4 - 
VAS – R 4 6 - 
VAS – M 9 1 - 
MMO 4 3 3 
TMDI 9 - 1 
Notes: The number of responders, non-responders and negative responders were 
calculated using MCID thresholds of 3.67 points for MPQSF- S,  1.33 points for 
MPQSF-A (Hawker et al., 2011), 20mm for VAS-R/M (Ostelo & de Vet, 2005), and 
5mm for MMO (Kropmans et al., 1999).  MPQSF-S/A= McGill Pain Questionnaire – 
Sensory and Affective; VAS-R/M = Visual Analogue Scale – Resting and Mastication; 
MMO = Maximal Mouth Opening; TMDI = Temporomandibular Disability Index. 
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3.3 Group Analysis 
  
Due to the consistency of clinical improvement across most of the enrolled participants, 
group statistical analyses were undertaken.  For the variables MPQSF-S-A, VAS-M and 
TMDI, skewness and kurtosis Z- scores for changes from baseline to end of intervention and 
baseline to follow-up were within the 95% confidence intervals for normal distribution.  VAS-
R distribution did not fit within normal boundaries at follow up and MMO did not fit within 
normal boundaries at baseline and end of intervention, however at follow up it was within 
normal boundaries.   
 
3.3.1  McGill Pain Questionnaire – Short Form 
 
Both sensory and affective MPQSF scores reduced from baseline throughout the treatment 
and follow-up periods (Figure 2 a & b & table 4).  Whilst repeated measures ANOVA showed 
a statistically significant change for sensory pain (P = 0.0001), with changes at end of 
intervention and follow up different from baseline, the change in affective score attained only 
borderline statistical significance (P = 0.08). (Table 3)  Post hoc analysis revealed significant 
sensory changes from baseline were seen from T2 to FU phases.  Effect sizes for changes 
(Cohen’s d) were large (Table 3)  
 
 
Figure 2 a & b. Changes in MPQSF scores from baseline for sensory and affective dimensions. Error bars show 
95% confidence intervals. Statistical significance was achieved for sensory data. Affective data reached 
borderline significance. Abbreviations are as follows: BL: Baseline (3 weeks); EI: End of week 6; FU: Follow Up 
(3 weeks). 
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3.3.2   Visual Analogue Scale – Resting and Mastication 
 
A reduction was observed in both masticatory and resting VAS scores from baseline to 
follow up (see figure 3 a & b; table 4).  Changes in VAS-R (P< 0.001) and VAS-M (P< 0.001) 
were both strongly statistically significant.  Post hoc analysis revealed baseline was 
statistically different from week two to follow-up for VAS-R and different from baseline across 
all time points for VAS-M.  Application of a non-parametric test (Friedman’s ANOVA), 
because of the possibility of non-normal distribution of the VAS-R variable, did not affect the 
outcome.  Very large effect sizes (Cohens d) were seen in both outcome measure of resting 
and masticatory VAS (Table 3).  MCID was reached for VAS-M.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3 a & b. Changes in VAS scores from baseline for Resting and mastication pain. Error bars show 95% 
confidence intervals. Statistical significance was achieved in both outcome measures. Measurements are made 
in centimetres. Abbreviations are as follows: BL: Baseline (3 weeks); EI: End of week 6; FU: Follow Up (3 
weeks). 
 
 
3.3.3   Maximal Mouth Opening 
 
Whilst an increasing trend in MMO from baseline to intervention and follow-up was shown, 
changes did attain statistical significance (Table 3).  Application of a non-parametric test 
(Friedman’s ANOVA), because of the possibility of non-normal distribution of the MMO 
variable, did not affect the outcome.  Effect sizes suggested an improvement from a small to 
moderate effect in MMO between the post intervention and follow up phases (Table 3) with 
Cohens d scores rising from 0.29 (EI) to 0.88 (FU).   
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Figure 4. Changes in MMO from baseline to follow up. Error bars show 95% confidence intervals. MMO did not 
achieve statistical significance. Measurements are in millimetres. Abbreviations are as follows: BL: Baseline (3 
weeks); EI: End of week 6; FU: Follow Up (3 weeks). 
 
 
3.3.4 TMD Disability Index 
 
A reduction is seen in TMDI scores from baseline to end of intervention and follow up (figure 
5).  Baseline means were heterogenous (table 4).  TMDI reached statistical significance with 
repeated measures ANOVA analysis (P=0.0001).  Post hoc analysis revealed baseline was 
statistically different from T2 to FU phases.  Large effect sizes (Cohen’s d) were seen at both 
end of intervention and follow up (table 3).   
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Changes in disability scores from baseline to follow up. Error bars show 95% confidence intervals. 
Statistical significance was achieved. Abbreviations as follows: BL: Baseline (3 weeks); EI: End of week 6; FU: 
Follow Up (3 weeks); TMDI: temporomandibular joint disability index. 
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 Table 3.  Cohen’s d (SRM) within group effect sizes 
 
 Post 
Intervention Follow Up 
ANOVA 
P Values 
Effect 
McGill-S -1.45 -1.66 0.0001 Large 
McGill-A -0.68 -0.95 0.08 Moderate 
VAS-R -2.44 -2.17 0.0001 Very Large 
VAS-M -1.86 -2.10 0.00001 Large 
MMO 0.29 0.88 0.243 Small – Moderate 
TMDI -1.39 -1.53 0.0001 Large 
 
 
 
Table 4: Mean baseline scores. Mean change and standard deviation from baseline to end of intervention and 
follow up 
 
 Mean BL Mean Δ EI Mean Δ FU MCID 
MPQSF – S 10.9 ± 5.98 5.5 ± 3.8 5.7 ± 3.4 3.67 
MPQSF – A 2.8 ± 2.2 1.2 ± 1.9 1.4 ± 1.9 1.33 
VAS – R 2.9 ± 1.5 16.1 ± 0.7 17.2 ± 0.8 20mm 
VAS – M 6.2 ± 1.9 33.5 ± 18 34.7 ± 17 20mm 
MMO 42.1 ± 6.5 2.7 ± 9.5 5.0 ± 5.8 5mm 
TMDI 10.95 ± 4.9 5.5 ± 3.97 5.7 ± 3.7 - 
Abbreviations: BL: Baseline; EI: End of intervention; FU: Follow up; Δ: change; MCID: Minimal Clinically 
important difference. 
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3.3.5  Intra-Class Correlation Co-efficients (ICC) 
 
ICC’s at follow up were high for reliability of the outcome variables MPQSF-S, VAS-R, VAS-
M and TMDI ranging from 0.67 to 0.86, and moderate for MPQSF-A and MMO.  (Table 5). 
 
 
Table 5. 
 ICC EI ICC FU 
MPQSF – S 0.83 0.84 
MPQSF – A 0.58 0.56 
VAS – R 0.91 0.86 
VAS – M 0.68 0.69 
MMO 0.13 0.52 
TMDI 0.69 0.67 
Abbreviations: ICC = Intra-class correlation co-efficients;  
EI: End of intervention; FU: Follow up. 
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4. DISCUSSION 
 
Research investigating the effects of osteopathic techniques on TMD is scarce..  Grouped 
results suggest that the use of intraoral osteopathic techniques for chronic 
temporomandibular joint disorders was effective for reducing nociceptive pain experience, 
emotional impact of pain, pain intensity at rest and upon mastication and disability.  The 
effects on emotional impact of pain and maximal mouth opening range are less clear, though 
effect size of emotional impact of pain was borderline.  Improvements across all participants 
in this study were relatively consistent and did not seem to be affected by participant gender 
or age. 
 
A single system research design (SSRD) was chosen as it is appropriate for investigating 
new techniques in smaller sample sizes where participants are hard to find (Cohen, 
Feinstein, Masuda, & Vowles, 2014) (Sanders, 2003).  An SSRD is useful for osteopathic 
research as it is a cost effective and simple way to investigate responses to interventions as 
a group or individual (Sanders, 2003).  This type of design is useful to conduct when 
resources are limited and is practical for investigating new treatments (Chan & Bhandari, 
2011).  On the contrary, as there is no control group, the strength of results may be affected 
as it can be uncertain if results came from the treatment or whether time alone caused 
change.  In this case, due to the chronic nature of participant presentations and duration of 
symptoms it would be unlikely that time alone resulted in the improvement, making it more 
likely that it was the intervention that caused the effect.  
 
4.1   Pain and disability  
 
A statistically significant decrease was seen in MPQSF sensory pain with 70% of 
participants showing a minimal clinically important change at follow-up.  Affective scores did 
not attain statistical significance at any time points, however, a MCID exceeding 1.33 was 
seen in 50% of participants.  According to Jaeschke, Singer, and Guyatt (1989), MCID refers 
to the smallest difference in score which participants perceive as beneficial.  This suggests 
that although the intervention effects were statistically stronger in those with sensory 
experience of nociceptive pain rather than affective emotional experience of pain, both 
results were of clinical importance at follow up.   
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Both resting and masticatory VAS scores had a statistically significant improvement.  A 
clinically important change was seen in 90% of VAS-M scores with one participant having no 
change.  In contrast, only 40% of participants reached the MCID of 20mm for VAS-R.  VAS-
R MCID problems resulted from five participants having baseline scores under 20mm, 
making it impossible to reach the clinical change needed.  Cao, Chen, and Fu (2008) found 
that TMD pain is more commonly present during functional activities and reporting of resting 
VAS scores are generally low making it difficult to reach the MCID for this outcome.  Reports 
have suggested that VAS data does not support calculations for MCID (Kersten, 
Küçükdeveci, & Tennant, 2012; Svensson, 2001).  Kersten et al. (2012) reported that VAS 
data is ordinal in nature suggesting that non-parametric testing be used rather than 
parametric.  Alternatively, Price, Staud, and Robinson (2012) disagreed stating that the ratio 
properties of some VAS have interval scales and therefore parametric analysis is 
appropriate.  Results from masticatory VAS fit into normal distribution of 95% confidence 
intervals, while resting VAS was normal at end of intervention phase.  No significant changes 
were seen when non-parametric testing was applied. 
 
A statistically significant reduction in TMD disability was seen from baseline through 
intervention and follow-up.  The reliability and validity of this questionnaire has yet to be 
evaluated, therefore findings are hypothetical predictors of patient perceptions rather than 
clinical importance and should be interpreted with caution.  A mean change of 5.7±3.7 and 
perceived disability decreased in 9 out of 10 participants.  Literature utilising the TMDI 
includes mostly case reports and one single cohort of n=15.  All had statistically significant 
results for those with disc reduction and in TMD with general upper cervical complex 
dysfunction (Cleland & Palmer, 2004; Cleland, Furto, Olson, & Whitman, 2006).   
 
The MPQSF addresses the multidimensional aspects of pain (McDowell, 2006).  It is one of 
the few tools capable of measuring both quantitative and qualitative pain responses and 
holds a high level of validity, reliability and consistency (Flaherty, 1996; McDowell, 2006).  
Literature utilising the MPQSF for TMD interventions are scarce, however, investigations into 
dominant descriptor words for TMD have been studied.  The most common pain descriptor 
reported by participants in this study was aching, followed by the sensory descriptors 
cramping and tender, and affective descriptor tiring/exhausting.  Vickers, Cousins, and 
Woodhouse (1998) found that in patients with orofacial pain, sensory words were the most 
commonly used, however, patients with concurrent conditions selected more affective 
descriptors.  Kafas, Chiotaki, Stavrianos, and Stavrianou (2007) reported that in people with 
chronic presentations the most common pain description was tender but in acute cases it 
was more likely to be sharp.  A better comparison to the words described in the current study 
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was by Cao et al. (2008) who found that aching, heavy and tender were the most common 
sensory words, and tiring/exhausting and sickening were the most common affective words.  
Sensory descriptors have shown a high association with VAS scores as seen in the current 
study when compared to masticatory VAS scores.  Alternatively the idea that affective 
scores would show a higher relationship with disability scores was not observed (Vickers et 
al., 1998). 
 
Some participants had difficulty with scoring using the VAS.  VAS is considered to be a 
simple to use measure, however validity and reliability has been argued (Carlsson, 1983).  
Participants were allowed to compare their scores with the previous scores recorded.  The 
reasoning was that participant verbal reporting and VAS reporting differed significantly. 
Participants would report that their pain was much improved from previously, however, when 
using the VAS, scores would be higher or vice versa.  When compared with previous scores 
participants were able to correctly report whether pain was higher or lower than previously. 
Reproduction of VAS scores is shown to be poorly administrated with participants tending to 
mark too high on the scale when reporting (Dixon & Bird, 1981).  VAS provides a more 
refined selection of pain intensity than the NRS and VRS, however, the VAS is thought to be 
harder to understand than the NRS, especially in illiterate subjects, it is more difficult to 
judge accurately and has with too much guesswork (Aitken, 1969; Ferraz, Quaresma, & 
1990; Jackson, Horn, Kersten. &, 2006).  VAS is a subjective measure and because pain is 
a complex personal and subjective experience, influenced by situation, attention, culture and 
psychosocial factors, the patient’s self-report provides the best measure (Melzack & Katz, 
2001). 
 
A significant number of studies investigating TMD used VAS as an outcome measure. 
Tuncer, Ergun, Tuncer, and Karahan (2013) measured resting pain VAS as well as stress 
pain VAS in TMD treatment with manual therapy and home physical therapy.  Pain with 
stress decreased with statistical significance while pain at rest did not reach statistical 
significance or MCID.  A larger change was seen in pain with stress (91.3%) than resting 
pain (59.2%).  Gonzalez-Iglesias, Cleland, Neto, Hall, and Fernandez-de-las-Penas (2013) 
used VAS as the primary outcome measure in a TMD intervention study.  Their VAS had a 0 
and 10 marked at either end giving it a numerical quality.  An MCID of only 9 to 11mm was 
utilised which was reported in studies by Gallagher (2001) and Bird (2001), making it easier 
to obtain clinical importance than the more recent 20mm MCID identified by Ostelo and de 
Vet (2005).  Statistical significance was achieved between baseline, end of intervention and 
at 2 month follow up with a large effect size of 1.4 which is smaller than the very large effect 
sizes seen in the current study.  A mean change of 25.7mm at end of intervention and 
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28.3mm at 2-month follow up were seen, suggesting that there was a large follow on effect 
from treatment similar to the current study.  Both interventions included manual therapy, 
Tuncer et al. (2013) included home physical therapy, massage, TMJ mobilisation and 
exercise along with cervical spine mobilisation.  Gonzalez-Iglesias et al. (2013) had a much 
broader approach utilising thoracic spine mobilisation and dry needling as well as TMJ 
mobilisation.  Gonzalez-Iglesias et al. (2013) used only myogenous type TMD participants, 
while Tuncer et al. (2013) used participants with a range of TMD types, similar to the current 
study, providing a much larger sample.  
 
 
4.2   Range of Motion 
 
Change in MMO scores reached 5.7mm indicating that although MMO did not obtain 
statistical significance, clinically important change of over 5mm was obtained (Kropmans et 
al., 1999).  Clinically important change was seen in 50% of participants at follow-up.  Effect 
of treatment was much greater at follow-up than at end of intervention reaching a moderate 
effect size of 0.9 indicating a possible follow on effect from the intervention had occurred. 
Participants undertook their own mouth opening measurements which may have resulted in 
increased score variability. 
 
MMO has been reported to be a reliable measure for TMD range of motion (Walker, 
Bohannon, & Cameron, 2000) with interrater reliability being satisfactory in trained 
examiners (Dworkin, LeResche, & DeRouen, 1988).  MMO measurement reliability problems 
were encountered when participants undertook their own measurements.  Participants were 
informed that measurements are taken from central incisor to lower central incisor however 
inter and intra rater consistency varied greatly, this was due in part to participants being 
careless or rushed, and difficulty reading the ruler and measuring at the same time.  To 
detect changes in the outcome of a variable, consistency in a measurement is vital.  This 
calls into question the therapeutic success of the intervention on MMO as accuracy of 
measurements obtained from participants was unknown.   
 
The use of MMO as a measurement for TMD has been utilised in a number of studies 
(Kalamir, Bonello, Graham, Vitiello, and Pollard, 2012; Hopkins, 2010; Kropmans et al., 
1999).  All studies investigated reached statistically significant change.  Kalamir, Bonello, 
Graham, Vitiello, and Pollard (2012) measured MMO using Vernier callipers resulting in a 
1mm margin of error and greater accuracy.  They estimated MCID between 5mm and 9mm 
as reported by Kropmans et al. (1999).  Hopkins (2010) used a clear ruler to measure MMO 
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in a sample of 12 symptomatic participants.  An MCD of 3mm was used rather than 5mm, 
however group analysis only reached 1.13mm change and only two participants reached the 
stated MCD.  An effect size of 0.92 was seen which is almost identical to this study.  The 
sample size was similar to the current study, however the technique used was muscle 
energy technique which suggests their osteopathic technique can elicit similar results.  
Gonzalez-Iglesias et al. (2013) also used a clear 10cm ruler for MMO with a change of 
11.4mm at end of intervention and 10.2mm at 2 month follow up.  This shows a much larger 
change than the current study and meets the upper range MCID of 9mm.  Participant 
baseline mean was 37.5mm which is 4.6mm smaller than the baseline of the current study 
which may account for the greater change.  All three studies used participants with 
myogenous TMD only, therefore MMO in discal and arthrogenic presentations is not 
discussed.  
 
 
4.3   Limitations 
 
Further to the limitations indicated in the discussion, this study had several other limitations.  
Firstly, a small sample size limits statistical power to detect a smaller effect and 
generalizability across the TMD population.  However, most of the results were statistically 
significant..  The short follow up period of only 3 weeks limits the ability to ascertain long 
term effects of the intervention.  Furthermore, the lack of reliability and validity of the TMDI 
questionnaire means that interpretation of the results should be done prudently.  
 
Recruitment of participants who did not reach MCID for resting VAS at baseline provided a 
limitation.  Participant scoring under these values cannot achieve the clinical change 
needed.  Selection of participants could have been more specific.  An inclusion criteria of 
scores exceeding MCID for all outcomes would deter this from happening in future studies.   
 
 
5. CONCLUSION 
 
Patients with TMD treated with intra-oral osteopathic techniques exhibited significant and 
clinically important change in pain intensity, pain experience and disability suggesting that 
use of these techniques in a clinical environment may have a positive effect on patient 
outcomes.  Future randomized controlled trials should be carried out using larger sample 
sizes and long-term follow-up periods in order to further determine the effects of these 
treatments on patients.  
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Figures 6a: McGill Pain Questionnaire – Short Form 
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Figure 6b:  Visual Analogue Scale – Resting and Mastication 
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Figure 6c: Maximal Mouth Opening Range 
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Figure 6c: Temporomandibular Disability Index 
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Information Sheet. 
 
 
 
 
 
 
 
You are invited to participate in our research investigations. Please read carefully through this information sheet 
before you make a decision about volunteering. 
 
My name is Helen Frederikson and I am a master of Osteopathy student at Unitec.  One of the requirements for 
completion of my post graduate degree includes undertaking a research thesis on a subject of my choice.  My 
research topic aims to determine whether intra-oral osteopathic techniques are effective in reducing pain and 
pain quality, improving range of motion and reducing disability in those suffering from jaw dysfunctions known 
as temporomandibular joint disorders. 
What I am doing 
The research projects primary objective is to investigate the effect of two intra-oral osteopathic techniques on 
patients suffering from a range of chronic temporomandibular joint disorders to guide a treatment protocol for 
future temporomandibular joint presentations.  By taking part in this research project you will be helping me to 
determine whether these specific techniques are effective in alleviating the pain and dysfunction that 
temporomandibular joint disorders cause. 
Who may participate 
I am looking for participants between the ages of 16-65 years old with a history of pain in the 
temporomandibular region for at least 6 weeks. 
What it will mean for you 
If you agree to participate, you will be emailed a questionnaire to complete and return to me and be required to 
undertake a physical examination to determine if your jaw problem is suitable for inclusion in this study.  If you 
are clinically applicable, you will be asked to sign a consent form.  This does not stop you from changing your 
mind if you wish to withdraw from the project. 
You will be involved in a 12 week study.  This will include 6 face to face consultations over 6 weeks where the 
intervention techniques will be performed. These consultations will take between 10 to 20 minutes and will be 
undertaken at the Unitec campus building 41.  Measurements will be taken twice weekly for the duration of the 
study including 2 weeks before the intervention and 3 weeks after the intervention depending on which group 
you are in. These measurements include simple pain scales, a questionnaire regarding the quality of pain and 
mouth opening measurements and do not require face to face consultation.   
Firstly, you will be involved in a face to face consultation (which will occur either at Unitecs Mt Albert campus, 
or at your home if it is more convenient for you).  This initial consultation will involve you filling out two 
questionnaires, an examination of your jaw movement and measurement of your opening ability and instructions 
on how to complete this. Further measurements will be required twice weekly which you will receive a text 
message or email reminder for.   
 
The Intervention treatment includes a type of muscle release to four muscles acting upon your jaw which places 
gentle pressure onto the muscle until it releases, and a gentle distraction and articulation technique with the aim 
to create space and improve mobility and nutrient movement through the joint. Each of these consultations 
should take no more than 10 minutes with another 10 minutes for gathering measurements. 
Your participation will enable me to further the development of techniques used in the osteopathic treatment 
approach for temporomandibular dysfunctions. 
Intra-oral osteopathic technique for chronic temporomandibular 
joint disorders. 
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Your name and any information that may identify you will be kept completely confidential.  All information 
collected from you will be stored on a password-protected computer and only myself as the researcher and my 
supervisor will have access to this information. 
I hope that you will take part and that you will find your involvement interesting.   
If you would like more information about the study please contact me as I am more than happy to discuss it with 
you.  Furthermore, if you have any concerns about the research project you are welcome to contact myself: 
 
Helen Frederikson 
Phone: 0212346676 or  
Email: h.frederikson@gmail.com 
 
Or you can contact my supervisor 
 
Jamie Mannion  
Phone +64 9 815 4321 ext  8404 or  
Email: jaymannion@gmail.com 
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Consent Form 
 
 
 
 
 
 
I have had the research project explained to me and I have read and understand the 
information sheet given to me. 
 
I understand that I am volunteering to partake in this study on my own will, and I may 
withdraw at any time up to the completion of the data collection aspect of the 
research project. 
 
I understand that none of the information I give will identify me. I also understand 
that all information that I give will be stored securely on a computer and Unitec for a 
period of 10 years. 
 
I understand that I can see the finished research document. 
 
I have had time to consider everything and I give my consent to be part of this 
project. 
 
Participant Signature: ………………………………………………………….  
Date:…………………………………… 
  
Intra-oral osteopathic technique for chronic temporomandibular 
joint disorders. 
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Appendix D: McGill Pain Questionnaire – Short Form 
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SHORT FORM McGILL PAIN QUESTIONNAIRE and PAIN SCORE 
 
Date: ______________________________________ 
Name: _____________________________________ 
 
Check the column (x) to indicate the level of your pain for each word, or leave 
blank if it does not apply to you. 
 
     Mild  Moderate  Severe 
 
1 Throbbing   _____   _____   _____ 
2 Shooting   _____   _____   _____ 
3 Stabbing   _____   _____   _____ 
4 Sharp   _____   _____   _____ 
5 Cramping   _____   _____   _____ 
6 Gnawing   _____   _____   _____ 
7 Hot-burning  _____   _____   _____ 
8 Aching   _____   _____   _____ 
9 Heavy   _____   _____   _____ 
10 Tender   _____   _____   _____ 
11 Splitting   _____   _____   _____ 
12 Tiring-Exhausting _____   _____   _____ 
13 Sickening   _____   _____   _____ 
14 Fearful   _____   _____   _____ 
15 Cruel-Punishing  _____   _____   _____ 
 
   
 
Indicate on this line how bad your pain is—at the left end of line means no pain 
at all, at right end means worst pain possible. 
 
  Pain at rest 
No __________________________________________ Worst Possible 
Pain                Pain 
 
  Pain on chewing or eating hard foods 
No __________________________________________ Worst Possible 
Pain                Pain 
 
Mouth opening range - ………………………………… 
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Mark (x) or comment on the below figure where you have your pain or problems 
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Appendix E: Temporomandibular Disability Index 
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TMD DISABILITY INDEX (STEIGERWALD/MAHER) 
NAME ___________________________________ M /F _____ AGE___________  
DATE_____________  
 
 
Please check the one statement that best pertains to you (not necessarily exactly) in each of the following 
categories. 
 
 
1.  Communication (talking) 
( )  I can talk as much as I want without pain, fatigue or discomfort. 
( )  I talk as much as I want, but it causes some pain, fatigue and/or discomfort. 
( )  I can't talk as much as I want because of pain, fatigue and/or discomfort. 
( )  I can't talk much at all because of pain, fatigue and/or discomfort. 
( )  Pain prevents me from talking at all. 
 
 
2.  Normal living activities (brushing teeth/flossing). 
( )  I am able to care for my teeth and gums in a normal fashion without restriction, and without pain, 
fatigue or discomfort. 
( )  I am able to care for all my teeth and gums, but I must be slow and careful, otherwise pain/discomfort, 
jaw tiredness results. 
( )  I do manage to care for my teeth and gums in a normal fashion, but it usually causes some 
pain/discomfort, jaw tiredness no matter how slow and careful I am. 
( ) I am unable to properly clean all my teeth and gums because of restricted opening and/or pain. 
( )  I am unable to care for most of my teeth and gums because of restricted opening and/or pain. 
 
 
3.  Normal living activities (eating, chewing). 
( )  I can eat and chew as much of anything I want without pain/discomfort or jaw tiredness. 
( )  I can eat and chew most anything I want, but it sometimes causes pain/discomfort and/or jaw tiredness. 
( )  I can't eat much of anything I want, because it often causes pain/discomfort, jaw tiredness or because of 
restricted opening. 
( )  I must eat only soft foods (consistency of scrambled eggs or less) because of pain/discomfort, jaw 
fatigue and/or restricted opening. 
( )  I must stay on a liquid diet because of pain and/or restricted opening. 
 
 
4.  Social/recreational activities (singing, playing musical instruments, cheering, laughing, social 
activities, playing amateur sports/hobbies, and recreation, etc.). 
( )  I am enjoying a normal social life and/or recreational activities without restriction. 
( )  I participate in normal social life and/or recreational activities but pain/discomfort is increased. 
( )  The presence of pain and/or fear of likely aggravation only limits the more energetic components of my 
social life (sports, exercising, dancing, playing musical instruments, singing). 
( )  I have restrictions socially, as I can't even sing, shout, cheer, play and/or laugh expressively because of 
increased pain/discomfort. 
( )  I have practically no social life because of pain. 
 
5. Non-specialized jaw activities (yawning, mouth opening and opening my mouth wide). 
( )  I can yawn in a normal fashion, painlessly. 
( )  I can yawn and open my mouth fully wide open, but sometimes there is discomfort. 
( )  I can yawn and open my mouth wide in a normal fashion, but it almost always causes discomfort. 
( )  Yawning and opening my mouth wide are somewhat restricted by pain. 
( )  I cannot yawn or open my mouth more than two finger widths (28-32 cm) or, if I can, it always causes 
greater than moderate pain. 
 
 
6.  Sleep (restful, nocturnal sleep pattern). 
( )  I sleep well in a normal fashion without any pain medication, relaxants or sleeping pills. 
( )  I sleep well with the use of pain pills, anti-inflammatory medication or medicinal sleeping aids. 
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( )  I fail to realize 6 hours restful sleep even with the use of pills. 
( )  I fail to realize 4 hours restful sleep even with the use of pills. 
( )  I fail to realize 2 hours restful sleep even with the use of pills. 
 
 
7.  Effects of any form of treatment, including, but not limited to, medications, in-office therapy, 
treatments, oral orthotics (e.g., splints, mouthpieces), ice/heat, etc. 
( )  I do not need to use treatment of any type in order to control or tolerate headache, face or jaw pain and 
discomfort. 
( )  I can completely control my pain with some form of treatment. 
( ) I get partial, but significant, relief through some form of treatment. 
( )  I don't get "a lot of" relief from any form of treatment. 
( )  There is no form of treatment that helps enough to make me want to continue. 
 
 
8.  Tinnitus, or ringing in the ear(s). 
( )  I do not experience ringing in my ear(s). 
( )  I experience ringing in my ear(s) somewhat, but it does not interfere with my sleep and/or my ability to 
perform my daily activities. 
( ) I experience ringing in my ear(s) and it interferes with my sleep and/or daily activities, but I can 
accomplish set goals and I can get an acceptable amount of sleep. 
( ) I experience ringing in my ear(s) and it causes a marked impairment in the performance of my daily 
activities and/or results in an unacceptable loss of sleep. 
( )  I experience ringing in my ear(s) and it is incapacitating and/or forces me to use a masking device to 
get any sleep. 
 
 
9.  Dizziness (lightheaded, spinning and/or balance disturbance). 
( )  I do not experience dizziness. 
( )  I experience dizziness, but it does not interfere with my daily activities. 
( )  I experience dizziness which interferes somewhat with my daily activities, but I can accomplish my set 
goals. 
( )  I experience dizziness which causes a marked impairment in the performance of my daily activities. 
( )  I experience dizziness which is incapacitating. 
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Appendix F:  Maximal Mouth Opening Ruler 
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Appendix G:  Ethics Approval Letters 
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Appendix H:  Western Leader Article 
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Appendix I: Recruitment Poster 
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Instruction for authors 
Source: http://www.journalofosteopathicmedicine.com/authorinfo 
 
The Editors of the Journal welcome contributions for publication from the following categories: Letters to the 
Editor and Editorials, Reviews and Original Research articles, Protocols, Commentaries, Education, Clinical and 
Practice articles (Case Studies) 
 
The Guidelines are separated into the following sections: 
 
A Online Submission 
B Types of Contributions 
C General Guidance 
D Preparation of the Manuscript 
E Specific Guidance for Original Research Articles 
F Specific Guidance for Protocols 
G Post Acceptance 
 
TYPES OF CONTRIBUTIONS - word limits exclude tables, figures and reference list. 
For all the following types of contributions authors are requested to consider the international readership of the 
journal and to be aware of the need to explain local contexts or define terminology where these are likely not to 
be commonly understood internationally. 
Reviews and Original Articles (2,000 - 5,000 words)  
These should be either (i) reports of new findings related to osteopathic medicine that are supported by research 
evidence. These should be original, previously unpublished works; or (ii) a critical or systematic review that seeks 
to summarise or draw conclusions from the established literature on a topic relevant to osteopathic medicine. 
Ethics in publishing 
 
For information on Ethics in publishing and Ethical guidelines for journal publication 
see  http://www.elsevier.com/publishingethicsand  http://www.elsevier.com/journal-authors/ethics. 
 
Human and animal rights 
 
If the work involves the use of animal or human subjects, the author should ensure that the work described has 
been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of 
Helsinki) for experiments involving humans http://www.wma.net/en/30publications/10policies/b3/index.html; EU 
Directive 2010/63/EU for animal experiments 
http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; Uniform Requirements for 
manuscripts submitted to Biomedical journals  http://www.icmje.org. Authors should include a statement in the 
manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of 
human subjects must always be observed. 
 
Patient anonymity 
Studies on patients or volunteers require ethics committee approval and informed consent which should be 
documented in the manuscript. 
 
Patients have a right to privacy. Therefore identifying information, including patients' images, names, initials, or 
hospital numbers, should not be included in videos, recordings, written descriptions, photographs, and pedigrees 
unless the information is essential for scientific purposes and you have obtained written informed consent for 
publication in print and electronic form from the patient (or parent, guardian or next of kin where applicable). If 
such consent is made subject to any conditions, Elsevier must be made aware of all such conditions. Evidence of 
written consent must be provided to Elsevier on request. 
 
Even where consent has been given, identifying details should be omitted if they are not essential. If identifying 
characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance 
that alterations do not distort scientific meaning and editors should so note. 
 
Authors submitting manuscripts as Case Reports, Case Problems, and Evidence in Practice should ensure that 
they have received consent from patients who are the subject of such reports. A statement to this effect should 
be included in the manuscript. 
 
If such consent has not been obtained, personal details of patients included in any part of the paper and in any 
supplementary materials (including all illustrations and videos) must be removed before submission. 
 
Conflict of interest 
 
All authors must disclose any financial and personal relationships with other people or organizations that could 
inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, 
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consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or 
other funding. If there are no conflicts of interest then please state this: 'Conflicts of interest: none'. See 
also  http://www.elsevier.com/conflictsofinterest. Further information and an example of a Conflict of Interest 
form can be found at:  http://help.elsevier.com/app/answers/detail/a_id/286/p/7923. 
 
Submission declaration 
 
Submission of an article implies that the work described has not been published previously (except in the form of 
an abstract or as part of a published lecture or academic thesis or as an electronic preprint, 
see  http://www.elsevier.com/sharingpolicy), that it is not under consideration for publication elsewhere, that its 
publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was 
carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in 
English or in any other language, without the written consent of the copyright-holder. 
 
IJOM Author Contribution Statement  
All manuscripts submitted to the journal should be accompanied by an Author Contribution Statement. The 
purpose of the Statement is to give appropriate credit to each author for their role in the study. All persons listed 
as authors should have made substantive intellectual contributions to the research. To qualify for authorship each 
person listed should have made contributions in each of the following; 
1) Contributions to conception and design; data acquisition; data analysis and interpretation; 
2) Drafting of manuscript, or critical revision for important intellectual content; 
3) All authors must have given approval to the final version of the manuscript submitted for consideration to 
publish. 
Acquisition of funding; provision of resources; data collection; or general supervision, alone, is not sufficient 
justification for authorship. Contributors who do not meet the criteria for authorship as outlined above should be 
listed in the Acknowledgements section. Acknowledgements may include contributions of technical assistance, 
proof reading and editing, or assistance with resources and funding. The statement may be published in the 
paper as appropriate. 
Example of suggested format (note the use of author initials). 
AB conceived the idea for the study. AB and CD contributed to the design and planning of the research. All 
authors were involved in data collection. AB and EF analysed the data. AB and CD wrote the first draft of the 
manuscript. EF coordinated funding for the project. All authors edited and approved the final version of the 
manuscript. 
 
Changes to authorship 
 
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted 
manuscripts: 
Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to 
rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted 
manuscript and must include: (a) the reason the name should be added or removed, or the author names 
rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, 
removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the 
author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the 
Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) 
Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted 
manuscript in an online issue is suspended until authorship has been agreed. 
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author 
names in an article published in an online issue will follow the same policies as noted above and result in a 
corrigendum. 
 
Clinical trial results 
 
In line with the position of the International Committee of Medical Journal Editors, the journal will not consider 
results posted in the same clinical trials registry in which primary registration resides to be prior publication if the 
results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, 
divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardise 
consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or 
closely related work. 
 
SPECIFIC GUIDANCE FOR ORIGINAL RESEARCH ARTICLES 
 
The text of original research for a quantitative or qualitative study is typically subdivided into the following 
sections: 
 
INTRODUCTION 
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Describe the wider context of the topic and its relevance providing selected citations that evidence and underpin 
the context. Identify key relevant research and briefly describe the strengths and weaknesses of past work and 
identify the gaps in the literature and key questions that are pertinent to the topic and practice. Build on this 
descriptive account to establish an argument for the manuscript’s focus and end the introductory section with the 
aims of the research that is being reported and or the research questions. 
 
Materials and Methods 
Describe your selection of observational or experimental participants (including controls). Identify the methods, 
apparatus (manufacturer's name and address in parenthesis) and procedures in sufficient detail to allow workers 
to reproduce the results. Give references and brief descriptions for methods that have been published but are not 
well known; describe new methods and evaluate limitations. 
 
Indicate whether procedures followed were in accordance with the ethical standards of the institution or regional 
committee responsible for ethical standards. Do not use patient names or initials. Take care to mask the identity 
of any participants in illustrative material. 
 
Results 
Present results in a logical sequence in the text, tables and illustrations. Do not repeat in the text all the data in 
the tables or illustrations. Emphasise or summarise only important observations. 
 
Discussion 
Emphasise the new and important aspects of the study and the conclusions that follow from them. Do not repeat 
in detail data or other material given in the introduction or the results section. Include implications of the findings 
and their limitations, and include implications for future research. Relate the observations to other relevant 
studies. Link the conclusion with the goals of the study, but avoid unqualified statements and conclusions not 
completely supported by your data. State new hypothesis when warranted, but clearly label them as such. 
Recommendations, when appropriate, may be included. 
 
Conclusion 
A summary of the pertinent findings and, relevance of the study and implications of the study for future research. 
 
Appendices - In addition to containing information regarding Acknowledgements, Appendices may also be used 
to publish supplementary files online, to which a reference should be made in the printed article. 
 
 
CONSIDERATIONS SPECIFIC TO TYPES OF RESEARCH DESIGNS 
 
Manuscripts are required to adhere to recognized reporting guidelines relevant to the research design used. 
These identify matters that should be addressed in your paper. These are not quality assessment frameworks 
and your study need not meet all the criteria implied in the reporting guideline to be worthy of publication in the 
journal. 
 
To improve the quality of reporting of other categories of research, the IJOM supports the initiatives available 
through the EQUATOR Network (Enhancing the Quality and Transparency Of health Research) which houses a 
database of all reporting guidelines for health research (http://www.equator-network.org). All authors of research 
articles and reviews are required to complete and submit a checklist from the appropriate reporting guideline 
together with your paper as a guide to the editors and reviewers of your paper. The checklists for each reporting 
guideline can be found on the EQUATOR website. 
 
Reporting guidelines endorsed by the journal are listed below: 
 
Observational cohort, case control and cross sectional studies - STROBE - Strengthening the Reporting of 
Observational Studies in Epidemiology http://www.equator-network.org/index.aspx?o=1032 
 
Quasi-experimental/non-randomised evaluations - TREND - Transparent Reporting of Evaluations with Non-
randomized Designshttp://www.equator-network.org/reporting-guidelines/improving-the-reporting-quality-of-
nonrandomized-evaluations-of-behavioral-and-public-health-interventions-the-trend-statement/  
 
Randomised (and quasi-randomised) controlled trial - CONSORT - Consolidated Standards of Reporting 
Trials http://www.equator-network.org/index.aspx?o=1032 
 
Study of Diagnostic accuracy/assessment scale - STARD - Standards for the Reporting of Diagnostic Accuracy 
Studieshttp://www.equator-network.org/index.aspx?o=1032 
 
Quality Appraisal of Reliability Studies - QAREL 
 
Consensus-based Clinical Case Reporting Guideline Development – CARE -http://www.equator-
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network.org/reporting-guidelines/care/ 
 
Systematic Review of Controlled Trials - PRISMA - Preferred Reporting Items for Systematic Reviews and Meta-
Analyseshttp://www.equator-network.org/index.aspx?o=1032 
 
Systematic Review of Observational Studies - MOOSE - Meta-analysis of Observational Studies in 
Epidemiology http://www.equator-network.org/index.aspx?o=1032 
 
Qualitative researchers might wish to consult the guideline listed below: 
 
Qualitative studies - COREQ - Consolidated criteria for reporting qualitative research. Tong, A., Sainsbury, P., 
Craig, J., 2007. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for 
interviews and focus groups. International Journal for Quality in Health Care 19 (6), 349-
357.  http://www.emgo.nl/kc/Analysis/statements/COREQ.pdf 
 
 
SPECIFIC GUIDANCE FOR PROTOCOLS 
 
Organisation of a Protocol - the following need to be adequately addressed. 
• Title 
• Abstract/Summary - this should provide a concise description of the purpose of the Protocol and should not 
exceed 200 words. 
• Background, including rationale and any previous systematic review(s). 
• Keywords - provide 4-10 keywords. 
• Principal investigator(s); contact details. 
• Aim(s). 
• Design (randomised, double-blind) - including inclusion and exclusion criteria; intervention(s)/method; primary 
and secondary endpoint(s); side-effects reporting and quantification 
• Statistical analysis - including sample size and power calculations; type of analysis; statistical testing. 
• Ethical issues - including ethics committee approval; informed consent form and information sheet. 
• Publication plan. 
• Time required - an estimation of the time required to run the protocol should be given per separate step and for 
the whole protocol, including reporting. 
• Funding source(s). 
• References. 
 
New guidance for randomised controlled trials 
 
The International Journal of Osteopathic Medicine has adopted the proposal from the International Committee of 
Medical Journal Editors(ICMJE) (see a recent Editorial in Manual 
Therapy  http://www.sciencedirect.com/science/article/pii/S1356689X1200238X, Editorial: "Clinical trial 
registration inphysiotherapy journals: Recommendations from the International Society of Physiotherapy Journal 
Editors"), which requires, as a condition of consideration for publication of clinical trials, registration in a public 
trials registry. Trials must register at or before the onset of patient enrolment. The clinical trial registration number 
should be included at the end of the abstract of the article. For this purpose, a clinical trial is defined as any 
research project that prospectively assigns human subjects to intervention or comparison groups to study the 
cause and effect relationship between a medical intervention and a health outcome. Studies designed for other 
purposes, such as to study pharmacokinetics or major toxicity (e.g. phase I trials) would be exempt. Further 
information can be found at  http://www.icmje.org. Clinical Trials that commence after 1st June 2013 must be 
registered to be considered for publication in the International Journal of Osteopathic Medicine. Authors will be 
asked to state the trial registration number during the submission system as well as at the end of the manuscript 
file. From January 2014 the International Journal of Osteopathic Medicine will not be able to accept any 
unregistered Clinical Trial papers. By 2015 the journal will not be able to publish any Clinical Trials that are 
unregistered prior to recruitment of the first participant. 
 
Copyright 
 
This journal offers authors a choice in publishing their research: Open Access and Subscription. For Subscription 
articles 
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more 
information on this and copyright, see  http://www.elsevier.com/copyright). An e-mail will be sent to the 
corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or 
a link to the online version of this agreement. Subscribers may reproduce tables of contents or prepare lists of 
articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required 
for resale or distribution outside the institution and for all other derivative works, including compilations and 
translations (please consult  http://www.elsevier.com/permissions). If excerpts from other copyrighted works 
are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in 
84 
 
the article. Elsevier has preprinted forms for use by authors in these cases: please 
consult  http://www.elsevier.com/permissions. 
 
For Open Access articles 
Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' (for more 
information see http://www.elsevier.com/OAauthoragreement). Permitted reuse of open access articles is 
determined by the author's choice of user license (see  http://www.elsevier.com/openaccesslicenses. 
 
Retained author rights 
As an author you (or your employer or institution) retain certain rights. For more information on author rights for: 
 
Subscription articles please see  http://www.elsevier.com/journal-authors/author-rights-and-responsibilities. 
 
Open access articles please see  http://www.elsevier.com/OAauthoragreement. 
 
 
Copyright 
 
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more 
information on this and copyright, see  http://www.elsevier.com/copyright). An e-mail will be sent to the 
corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or 
a link to the online version of this agreement. 
 
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation 
within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and 
for all other derivative works, including compilations and translations (please 
consult  http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the 
author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier 
has preprinted forms for use by authors in these cases: please consult  http://www.elsevier.com/permissions. 
 
For open access articles: Upon acceptance of an article, authors will be asked to complete an 'Exclusive License 
Agreement' (for more information see  http://www.elsevier.com/OAauthoragreement). Permitted third party 
reuse of open access articles is determined by the author's choice of user license 
(see  http://www.elsevier.com/openaccesslicenses). 
 
Author rights 
As an author you (or your employer or institution) have certain rights to reuse your work. For more information 
see http://www.elsevier.com/copyright. 
 
Role of the funding source 
 
You are requested to identify who provided financial support for the conduct of the research and/or preparation of 
the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and 
interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the 
funding source(s) had no such involvement then this should be stated. 
 
Funding body agreements and policies 
 
Elsevier has established a number of agreements with funding bodies which allow authors to comply with their 
funder's open access policies. Some authors may also be reimbursed for associated publication fees. To learn 
more about existing agreements please visit  http://www.elsevier.com/fundingbodies. 
After acceptance, open access papers will be published under a noncommercial license. For authors requiring a 
commercial CC BY license, you can apply after your manuscript is accepted for publication. 
 
Open access 
 
This journal offers authors a choice in publishing their research:  
 
Open access  
• Articles are freely available to both subscribers and the wider public with permitted reuse  
• An open access publication fee is payable by authors or on their behalf e.g. by their research funder or 
institution 
Subscription 
• Articles are made available to subscribers as well as developing countries and patient groups through our 
universal access programs (  http://www.elsevier.com/access).  
• No open access publication fee payable by authors.  
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Regardless of how you choose to publish your article, the journal will apply the same peer review criteria and 
acceptance standards.  
 
For open access articles, permitted third party (re)use is defined by the following Creative Commons user 
licenses: 
 
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 
 
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such 
as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article. 
 
The open access publication fee for this journal is USD 1700, excluding taxes. Learn more about Elsevier's 
pricing policy: http://www.elsevier.com/openaccesspricing. 
 
Language (usage and editing services) 
 
Please write your text in good English (American or British usage is accepted, but not a mixture of these). 
Authors who feel their English language manuscript may require editing to eliminate possible grammatical or 
spelling errors and to conform to correct scientific English may wish to use the English Language Editing service 
available from Elsevier's WebShop ( http://webshop.elsevier.com/languageediting/) or visit our customer 
support site (  http://support.elsevier.com) for more information. 
 
Submission 
 
Our online submission system guides you stepwise through the process of entering your article details and 
uploading your files. The system converts your article files to a single PDF file used in the peer-review process. 
Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, 
including notification of the Editor's decision and requests for revision, is sent by e-mail. 
 
Submit your article 
 
Please submit your article via  http://ees.elsevier.com/ijom/. 
 
Referees 
 
Please submit the names and institutional e-mail addresses of several potential referees. For more details, visit 
our Support site. Note that the editor retains the sole right to decide whether or not the suggested reviewers are 
used. 
 
Preparation 
 
• Submitted papers should be relevant to an international audience and authors should not assume knowledge of 
national practices, policies, law, etc. Authors should consult a recent issue of the journal for style if possible. 
Since the journal is distributed all over the world, and as English is a second language for many readers, authors 
are requested to write in plain English and use terminology which is internationally acceptable. 
 
Abbreviations - Avoid the use of abbreviations unless they are likely to be widely recognised. In particular you 
should avoid abbreviating key concepts in your paper where readers might not already be familiar with the 
abbreviation. Any abbreviations which the authors intend to use should be written out in full and followed by the 
letters in brackets the first time they appear, thereafter only the letters without brackets should be used. Statistics 
- Standard methods of presenting statistical material should be used. Where methods used are not widely 
recognised explanation and full reference to widely accessible sources must be given. 
 
Review Process  
The decision to publish a paper is based on an editorial assessment and peer review. Initially all papers are 
assessed by an editor of the journal. The prime purpose is to decide whether to send a paper for peer review and 
to give a rapid decision on those that are not. 
 
Manuscripts going forward to the review process are reviewed by members of an international expert panel. All 
such papers will undergo a double blind peer review by two or more reviewers. All papers are subject to peer 
review and the Journal takes every reasonable step to ensure author identity is concealed during the review 
process. The Editors reserve the right to the final decision regarding acceptance. 
 
Double-blind peer review - This journal uses double-blind review, which means that both the reviewer and author 
name(s) are not allowed to be revealed to one another for a manuscript under review. The identities of the 
authors are concealed from the reviewers, and vice versa. To facilitate anonymity, the author's names and any 
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reference to their addresses should only appear on the title page. 
 
Blinded manuscript (no author details): The main body of the paper (including the references, figures, tables and 
any Acknowledgements) should not include any identifying information, such as the authors' names or affiliations. 
Authors should also ensure that the place of origin of the work or study, and/or the organization(s) that have been 
involved in the study/development are not revealed in the manuscript – “X” can be used in the manuscript and 
details can be completed if the manuscript is processed further through the publication process. 
 
NEW SUBMISSIONS 
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and 
uploading of your files. The system automatically converts your files to a single PDF file, which is used in the 
peer-review process. 
 
As part of the Your Paper Your Way service, you may choose to submit your manuscript as a single file to be 
used in the refereeing process. This can be a PDF file or a Word document, in any format or lay-out that can be 
used by referees to evaluate your manuscript. It should contain high enough quality figures for refereeing. If you 
prefer to do so, you may still provide all or some of the source files at the initial submission. Please note that 
individual figure files larger than 10 MB must be uploaded separately 
 
References 
There are no strict requirements on reference formatting at submission. References can be in any style or format 
as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article 
title, year of publication, volume number/book chapter and the pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the 
proof stage. Note that missing data will be highlighted at proof stage for the author to correct. 
 
Formatting requirements 
There are no strict formatting requirements but all manuscripts must contain the essential elements needed to 
convey your manuscript, for example Abstract, Keywords, Introduction, Materials and Methods, Results, 
Conclusions, Artwork and Tables with Captions and "Contribution of Paper" (where applicable). 
 
If your article includes any Videos and/or other Supplementary material, this should be included in your initial 
submission for peer review purposes. 
 
Divide the article into clearly defined sections. 
 
Figures and tables embedded in text 
Please ensure the figures and the tables included in the single file are placed next to the relevant text in the 
manuscript, rather than at the bottom or the top of the file. Ensure that figures and tables are referred to in the 
body of the text and that they are clearly labelled. 
 
ALL SUBMISSIONS 
The following documents are needed for all submissions. 
 
Title page (with author details) – This should include the title, authors' names and affiliations, and a complete 
address for the corresponding author including telephone and e-mail address. 
 
Blinded manuscript (no author details) – The main body of the paper (including the references, figures, tables 
and any Acknowledgements) should not include any identifying information, such as the authors' names or 
affiliations. 
 
Covering letter – to the editor in which you detail authorship contributions and other matters you wish the editors 
to consider. 
 
What this paper adds 
At submission stage, authors of reviews and original research articles are required to provide three to four bullet 
points outlining what the manuscript adds to the literature. This should succinctly and accurately summarise the 
key new knowledge resulting from the study along with the implications for clinical, educational or research 
practice as appropriate for the focus of the manuscript. 
 
Manuscript Layout 
The manuscript with a font size of 12 or 10 pt double-spaced with wide margins (2.5 cm at least) and number 
pages consecutively beginning with the Title Page. Depending on the paper type (see above) this should include 
the title, abstract, key words, text, references, tables, figure legends, figures, appendix. Microsoft Word or similar 
programme should be used. 
Please check your typescript carefully before you send it off, both for correct content and typographic errors. It is 
not possible to change the content of accepted typescripts during production. 
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To facilitate anonymity, the author's names and any reference to their addresses should only appear on the title 
page. Please check your typescript carefully before you send it off, both for correct content and typographic 
errors. It is not possible to change the content of accepted typescripts during production. 
 
Text  
The text of observational and experimental articles is usually, but not necessarily, divided into sections with the 
headings; introduction, methods, results, results and discussion. In longer articles, headings should be used only 
to enhance the readability. Three categories of headings should be used: 
 
• major headings should be typed in capital letter in the centre of the page and underlined (i.e. INTRODUCTION) 
 
• secondary ones should be typed in lower case (with an initial capital letter) in the left hand margin and 
underlined (i.e. Participants). 
 
• minor ones typed in lower case and italicised (i.e. questionnaire). 
 
Do not use 'he', 'his' etc. where the sex of the person is unknown; say 'the patient' etc. Avoid inelegant 
alternatives such as 'he/she'. 
 
Essential title page information 
 
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and 
formulae where possible. 
• Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author 
and check that all names are accurately spelled. Present the authors' affiliation addresses (where the actual work 
was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the 
author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including 
the country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and 
publication, also post-publication. Ensure that the e-mail address is given and that contact details are kept 
up to date by the corresponding author. 
• Present/permanent address. If an author has moved since the work described in the article was done, or was 
visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's 
name. The address at which the author actually did the work must be retained as the main, affiliation address. 
Superscript Arabic numerals are used for such footnotes. 
 
 
GENERAL GUIDANCE 
 
Abstract  
Both qualitative and quantitative research approaches should be accompanied by a structured abstract of no 
more than 250 words. Commentaries and Essays may continue to use text based abstracts of no more than 150 
words. All original articles should include the following headings in the abstract as appropriate: Background, 
Objective, Design, Setting, Methods, Participants, Results, and Conclusions. As an absolute minimum: 
Objectives, Methods, Results, and Conclusions must be provided for all original articles. Abstracts for reviews of 
the literature (in particular systematic reviews and meta-analysis) should include the following headings as 
appropriate: Objectives, Data Sources, Study Selection, Data Extraction, Data Synthesis, Conclusions. Abstracts 
for Case Studies should include the following headings as appropriate: Background, Objectives, Clinical 
Features, Intervention and Outcomes, Conclusions. 
 
Keywords  
Include four to ten keywords in alphabetical order, which accurately identify the paper's subject, purpose, method 
and focus. These should be indexing terms that may be published with the abstract with the aim of increasing the 
likely accessibility of your paper to potential readers searching the literature. Therefore, ensure keywords are 
descriptive of the study. Use the Medical Subject Headings (MeSH®) thesaurus or Cumulative Index to Nursing 
and Allied Health (CINAHL) headings where possible (seehttp://www.nlm.nih.gov/mesh/meshhome.html). 
 
Abbreviations- Avoid the use of abbreviations unless they are likely to be widely recognised. In particular you 
should avoid abbreviating key concepts in your paper where readers might not already be familiar with the 
abbreviation. Any abbreviations which the authors intend to use should be written out in full and followed by the 
letters in brackets the first time they appear, thereafter only the letters without brackets should be used. 
 
Acknowledgments  
In the appendix one or more statements should specify (a) contributions that need acknowledging, but do not 
justify authorship (b) acknowledgments of technical support (c) acknowledgments of financial and material 
support, specifying the nature of the support. Persons named in this section must have given their permission to 
be named. Authors are responsible for obtaining written permission from those acknowledged by name since 
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readers may infer their endorsement of the data and conclusions. 
 
Statement of Competing Interests  
When submitting a manuscript you will need to consider if you, or any of your co-authors, are an Editor or 
Editorial Board member of the International Journal of Osteopathic Medicine. If this is the case you will need to 
include a section, at the end of your manuscript immediately before the reference section, called "Statement of 
Competing Interests". Example statement, which may require editing, is as follows: {Name of author} is an Editor 
of the Int J Osteopath Med; {Name of author} is a member of the Editorial Board of the Int J Osteopath Med but 
was not involved in review or editorial decisions regarding this manuscript. 
Artwork 
 
File Formatting for Artwork &Illustrations - General points 
 
• Make sure you use uniform lettering and sizing of your original artwork. 
• Save text in illustrations as "graphics" or enclose the font. 
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol. 
• Number the illustrations according to their sequence in the text. 
• Use a logical naming convention for your artwork files. 
• Provide captions to illustrations separately. 
• Produce images near to the desired size of the printed version. 
• Submit each figure as a separate file. 
 
A detailed guide on electronic artwork is available on our website: http://www.elsevier.com/artworkinstructions 
 
Please do not: 
• Supply embedded graphics in your word processor (spreadsheet, presentation) document. 
• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low. 
• Supply files that are too low in resolution. 
• Submit graphics that are disproportionately large for the content. 
 
Electronic artwork 
 
General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Embed the used fonts if the application provides that option.  
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or use fonts that 
look similar.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
• Size the illustrations close to the desired dimensions of the published version.  
• Submit each illustration as a separate file.  
A detailed guide on electronic artwork is available on our website:  
 http://www.elsevier.com/artworkinstructions. 
You are urged to visit this site; some excerpts from the detailed information are given here. 
 
Formats 
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please 
supply 'as is' in the native document format.  
Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please 
'Save as' or convert the images to one of the following formats (note the resolution requirements for line 
drawings, halftones, and line/halftone combinations given below):  
EPS (or PDF): Vector drawings, embed all used fonts.  
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.  
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.  
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of 500 dpi. 
Please do not:  
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number 
of pixels and limited set of colors;  
• Supply files that are too low in resolution;  
• Submit graphics that are disproportionately large for the content. 
 
Tables, Illustrations and Figures  
Tables, illustrations and figures should be placed on separate pages as separate electronic files and not placed 
within the manuscript. Each table, illustration or figure should be accompanied by a number (e.g. Table 1) and a 
brief description of the content of the table, figure or illustration, below the table, illustration or figure. All tables, 
illustrations or figures should be referred to in the manuscript. 
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Illustrations and tables that have appeared elsewhere must be accompanied by written permission to 
reproduce them from the original publishers. This is necessary even if you are an author of the borrowed 
material. Borrowed material should be acknowledged in the captions in the exact wording required by the 
copyright holder. If not specified, use this style: `Reproduced by kind permission of . . . (publishers) from . . . 
(reference).' Identifiable clinical photographs must be accompanied by written permission from the patient. 
 
References 
 
Citation in text 
 
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any 
references cited in the abstract must be given in full. Unpublished results and personal communications are not 
recommended in the reference list, but may be mentioned in the text. If these references are included in the 
reference list they should follow the standard reference style of the journal and should include a substitution of 
the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in 
press' implies that the item has been accepted for publication. 
 
Reference links 
 
Increased discoverability of research and high quality peer review are ensured by online links to the sources 
cited. In order to allow us to create links to abstracting and indexing services, such as Scopus, CrossRef and 
PubMed, please ensure that data provided in the references are correct. Please note that incorrect surnames, 
journal/book titles, publication year and pagination may prevent link creation. When copying references, please 
be careful as they may already contain errors. Use of the DOI is encouraged. 
 
Web references 
 
As a minimum, the full URL should be given and the date when the reference was last accessed. Any further 
information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. 
Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can 
be included in the reference list. 
 
Reference formatting 
 
There are no strict requirements on reference formatting at submission. References can be in any style or format 
as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article 
title, year of publication, volume number/book chapter and the pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the 
proof stage. Note that missing data will be highlighted at proof stage for the author to correct. If you do wish to 
format the references yourself they should be arranged according to the following examples: 
 
Text: Indicate references by superscript numbers in the text. These should appear at the end of the relevant 
sentence and should be directly after punctuation. The actual authors can be referred to, but the reference 
number(s) must always be given. 
 
List: Number the references in the list in the order in which they appear in the text. 
 
Examples: 
 
Reference to a journal publication: 
 
1. Thomson OP, Petty NJ, Moore AP. Reconsidering the patient-centeredness of osteopathy. Int J Osteopath 
Med 2012;16:25-32. 
 
Reference to a book: 
 
2. Cohen J. Statistical power analysis for the behavioral sciences . 2nd ed. Hillsdale, NJ: Laurence Erlbaum 
Associates; 1988. 
 
Reference to a chapter in an edited book: 
 
3. Patel VL, Kauffman DR. Clinical reasoning and biomedical knowledge: implications for teaching. In: Higgs J, 
Jones M, editors. Clinical reasoning in the health professions .2nd ed. Oxford: Butterworth-Heinemann; 2000. P. 
33-44. 
 
For journal articles, the abbreviated title of the journal should be used. Authors should refer to the National 
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Library of Medicine database for journal abbreviations (http://www.ncbi.nlm.nih.gov/nlmcatalog/journals). 
 
Note shortened form for last page number. (e.g., 51-9), and that for more than 6 authors the first 6 should be 
listed followed by "et al." For further details you are referred to "Uniform Requirements for Manuscripts submitted 
to Biomedical Journals" (J Am Med Assoc 1997;277:927-934) (see 
also http://www.nejm.org/general/text/requirements/1.htm). 
 
AudioSlides 
 
The journal encourages authors to create an AudioSlides presentation with their published article. AudioSlides 
are brief, webinar-style presentations that are shown next to the online article on ScienceDirect. This gives 
authors the opportunity to summarize their research in their own words and to help readers understand what the 
paper is about. More information and examples are available at  http://www.elsevier.com/audioslides. Authors 
of this journal will automatically receive an invitation e-mail to create an AudioSlides presentation after 
acceptance of their paper. 
 
Submission checklist 
 
The following list will be useful during the final checking of an article prior to sending it to the journal for review. 
Please consult this Guide for Authors for further details of any item.  
Ensure that the following items are present:  
One author has been designated as the corresponding author with contact details:  
• E-mail address  
• Full postal address  
All necessary files have been uploaded, and contain:  
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been 'spell-checked' and 'grammar-checked'  
• References are in the correct format for this journal  
• All references mentioned in the Reference list are cited in the text, and vice versa  
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)  
Printed version of figures (if applicable) in color or black-and-white  
• Indicate clearly whether or not color or black-and-white in print is required.  
• For reproduction in black-and-white, please supply black-and-white versions of the figures for printing 
purposes.  
For any further information please visit our customer support site at  http://support.elsevier.com. 
 
Please check the manuscript carefully before it is sent off to the Editorial Office, both for correct content and 
typographical errors, as it is not possible to change the content of accepted typescripts during the production 
process. As a guide, please ensure the following had been included: 
 
• One copy of manuscript and; 
• Tables, figures and illustrations, uploaded separately and correctly labelled; 
• Reference list in correct style and correct in-text referencing; 
• Written permission from original publishers and authors to reproduce any borrowed any borrowed material 
(where relevant). 
 
Statistics 
 
Statistics - Standard methods of presenting statistical material should be used. Where methods used are not 
widely recognised explanation and full reference to widely accessible sources must be given. 
 
REVISED SUBMISSIONS 
 
At revision stage the following documentation is required: 
• a separate "Response to Reviewers" file – Responses to the reviewers' and editors' comments. 
• a revised blinded manuscript with changes clearly highlighted. 
 
Revised submissions should be accompanied by a letter which responds point by point to the reviewers' and 
editors' comments, and changes to the revised paper should be highlighted so they can be spotted easily by the 
reviewers to whom the paper is normally returned for further review/comment.  
 
Use of word processing software 
Regardless of the file format of the original submission, at revision you must provide us with an editable file of the 
entire article. Keep the layout of the text as simple as possible. Most formatting codes will be removed and 
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replaced on processing the article. The electronic text should be prepared in a way very similar to that of 
conventional manuscripts (see also the Guide to Publishing with 
Elsevier: http://www.elsevier.com/guidepublication). See also the section on Electronic artwork. 
 
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of 
your word processor. 
 

